ID   HBA_HUMAN               Reviewed;         142 AA.
AC   P69905; P01922; Q1HDT5; Q3MIF5; Q53F97; Q96KF1; Q9NYR7; Q9UCM0;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   20-JUN-2018, entry version 173.
DE   RecName: Full=Hemoglobin subunit alpha;
DE   AltName: Full=Alpha-globin;
DE   AltName: Full=Hemoglobin alpha chain;
GN   Name=HBA1;
GN   and
GN   Name=HBA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA1).
RX   PubMed=7448866; DOI=10.1016/0092-8674(80)90347-5;
RA   Michelson A.M., Orkin S.H.;
RT   "The 3' untranslated regions of the duplicated human alpha-globin
RT   genes are unexpectedly divergent.";
RL   Cell 22:371-377(1980).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (HBA2).
RX   PubMed=6244294;
RA   Wilson J.T., Wilson L.B., Reddy V.B., Cavallesco C., Ghosh P.K.,
RA   Deriel J.K., Forget B.G., Weissman S.M.;
RT   "Nucleotide sequence of the coding portion of human alpha globin
RT   messenger RNA.";
RL   J. Biol. Chem. 255:2807-2815(1980).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA2).
RX   PubMed=6452630; DOI=10.1073/pnas.77.12.7054;
RA   Liebhaber S.A., Goossens M.J., Kan Y.W.;
RT   "Cloning and complete nucleotide sequence of human 5'-alpha-globin
RT   gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 77:7054-7058(1980).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6946451; DOI=10.1073/pnas.78.8.5041;
RA   Orkin S.H., Goff S.C., Hechtman R.L.;
RT   "Mutation in an intervening sequence splice junction in man.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:5041-5045(1981).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-32.
RX   PubMed=11410421;
RA   Zhao Y., Xu X.;
RT   "Alpha2(CD31 AGG-->AAG, Arg-->Lys) causing non-deletional alpha-
RT   thalassemia in a Chinese family with HbH disease.";
RL   Haematologica 86:541-542(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA1).
RX   PubMed=11402454;
RA   Zhao Y., Zhong M., Liu Z., Xu X.;
RT   "Rapid detection of the common alpha-thalassemia-2 determinants by PCR
RT   assay.";
RL   Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:216-218(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALPHA-1 AND ALPHA-2).
RX   PubMed=16728641; DOI=10.1126/science.1126431;
RA   De Gobbi M., Viprakasit V., Hughes J.R., Fisher C., Buckle V.J.,
RA   Ayyub H., Gibbons R.J., Vernimmen D., Yoshinaga Y., de Jong P.,
RA   Cheng J.-F., Rubin E.M., Wood W.G., Bowden D., Higgs D.R.;
RT   "A regulatory SNP causes a human genetic disease by creating a new
RT   transcriptional promoter.";
RL   Science 312:1215-1217(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (HBA2).
RC   TISSUE=Blood;
RA   Kutlar F., Leithner C., Kutlar A.;
RT   "Rapid sequencing of mRNA of the human alpha two globin, directly
RT   isolated from reticulocytes in whole blood.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (HBA1).
RC   TISSUE=Blood;
RA   Kutlar F., Leithner C., Kutlar A.;
RT   "cDNA sequencing of human alpha one globin mRNA, the 3'untranslated
RT   region is different than alpha two globin.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RA   Kutlar F., Holley L., Leithner C., Kutlar A.;
RT   "An alpha chain variant 'Hemoglobin J-Toronto (Cd.5 /Ala to Asp)'
RT   mutation was detected on the alpha-1 globin mRNA by sequencing of
RT   cDNA.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA2), AND VARIANT EVANS MET-63.
RC   TISSUE=Blood;
RA   Kutlar F., Elam D., Hoff J.V., Holley L., Kutlar A.;
RT   "Unstable Hb 'Evans' (GTG->ATG/Val 62 Met) was detected on the alpha-2
RT   globin gene of an Hispanic girl.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA2), AND VARIANT G-PHILADELPHIA
RP   LYS-69.
RA   Kutlar F., Davis D.H., Nechtman J., Elam D.;
RT   "Hb G-Philadelphia (Alpha,Codon 68;AAC>AAG/Asn>Lys)in black is
RT   detected on a chromosome that carries alpha 3.7 kb deletion showed
RT   completely normal alpha-2 globin gene sequence.";
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HBA1 AND HBA2).
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K.,
RA   Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J.,
RA   Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2
RT   Mb of the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HBA1 AND HBA2).
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (HBA1 AND HBA2).
RC   TISSUE=Bone marrow, Brain, Lung, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   PROTEIN SEQUENCE OF 2-142.
RX   PubMed=13872627; DOI=10.1515/bchm2.1961.325.1.283;
RA   Braunitzer G., Gehring-Muller R., Hilschmann N., Hilse K., Hobom G.,
RA   Rudloff V., Wittmann-Liebold B.;
RT   "The constitution of normal adult human haemoglobin.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 325:283-286(1961).
RN   [18]
RP   PROTEIN SEQUENCE OF 2-142.
RX   PubMed=13954546;
RA   Hill R.J., Konigsberg W.;
RT   "The structure of human hemoglobin: IV. The chymotryptic digestion of
RT   the alpha chain of human hemoglobin.";
RL   J. Biol. Chem. 237:3151-3156(1962).
RN   [19]
RP   PROTEIN SEQUENCE OF 2-142.
RX   PubMed=14093912; DOI=10.1021/bi00906a030;
RA   Schroeder W.A., Shelton J.R., Shelton J.B., Cormick J.;
RT   "The amino acid sequence of the alpha chain of human fetal
RT   hemoglobin.";
RL   Biochemistry 2:1353-1357(1963).
RN   [20]
RP   PROTEIN SEQUENCE OF 2-32.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [21]
RP   PROTEIN SEQUENCE OF 128-142, AND VARIANT ETHIOPIA HIS-141.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=1428951; DOI=10.3109/03630269209005699;
RA   Webber B.B., Wilson J.B., Gu L.-H., Huisman T.H.J.;
RT   "Hb Ethiopia or alpha 2(140)(HC2)Tyr----His beta 2.";
RL   Hemoglobin 16:441-443(1992).
RN   [22]
RP   GLYCATION AT LYS-8; LYS-17; LYS-41 AND LYS-62, AND LACK OF GLYCATION
RP   AT LYS-12; LYS-57; LYS-61; LYS-91 AND LYS-100.
RX   PubMed=7358733;
RA   Shapiro R., McManus M.J., Zalut C., Bunn H.F.;
RT   "Sites of nonenzymatic glycosylation of human hemoglobin A.";
RL   J. Biol. Chem. 255:3120-3127(1980).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; THR-9; TYR-25; SER-36
RP   AND SER-50, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF DEOXYHEMOGLOBIN.
RX   PubMed=1177322; DOI=10.1016/S0022-2836(75)80037-4;
RA   Fermi G.;
RT   "Three-dimensional Fourier synthesis of human deoxyhaemoglobin at 2.5-
RT   A resolution: refinement of the atomic model.";
RL   J. Mol. Biol. 97:237-256(1975).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=7373648; DOI=10.1016/0022-2836(80)90308-3;
RA   Baldwin J.M.;
RT   "The structure of human carbonmonoxy haemoglobin at 2.7-A
RT   resolution.";
RL   J. Mol. Biol. 136:103-128(1980).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF LIGANDED R2 STATE.
RX   PubMed=1512262;
RA   Silva M.M., Rogers P.H., Arnone A.;
RT   "A third quaternary structure of human hemoglobin A at 1.7-A
RT   resolution.";
RL   J. Biol. Chem. 267:17248-17256(1992).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF HB GOWER-2.
RX   PubMed=9665850; DOI=10.1006/jmbi.1998.1868;
RA   Sutherland-Smith A.J., Baker H.M., Hofmann O.M., Brittain T.,
RA   Baker E.N.;
RT   "Crystal structure of a human embryonic haemoglobin: the carbonmonoxy
RT   form of Gower II (alpha2 epsilon2) haemoglobin at 2.9-A resolution.";
RL   J. Mol. Biol. 280:475-484(1998).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF VARIANT HB CATONSVILLE GLU-38
RP   INS.
RX   PubMed=8448109; DOI=10.1021/bi00061a007;
RA   Kavanaugh J.S., Moo-Penn W.F., Arnone A.;
RT   "Accommodation of insertions in helices: the mutation in hemoglobin
RT   Catonsville (Pro 37 alpha-Glu-Thr 38 alpha) generates a 3(10)-->alpha
RT   bulge.";
RL   Biochemistry 32:2509-2513(1993).
RN   [32]
RP   VARIANT J-CAPE TOWN GLN-93.
RX   PubMed=5988206; DOI=10.1038/212792a0;
RA   Botha M.C., Beale D., Isaacs W.A., Lehmann H.;
RT   "Hemoglobin J Cape Town-alpha-2 92 arginine replaced by glutamine
RT   beta-2.";
RL   Nature 212:792-795(1966).
RN   [33]
RP   VARIANT BIBBA PRO-137.
RX   PubMed=5440849;
RA   Smith L.L., Barton B.P., Huisman T.H.;
RT   "Subunit dissociation of the unstable hemoglobin Bibba (alpha 2-
RT   136Pro(H19)beta 2).";
RL   J. Biol. Chem. 245:2185-2188(1970).
RN   [34]
RP   CHARACTERIZATION OF VARIANT J-CAPE TOWN GLN-93.
RX   PubMed=5091982; DOI=10.1016/0022-2836(71)90029-5;
RA   Nagel R.L., Gibson Q.H., Jenkins T.;
RT   "Ligand binding in hemoglobin J Capetown.";
RL   J. Mol. Biol. 58:643-650(1971).
RN   [35]
RP   VARIANT HOPKINS-II ASP-113.
RX   PubMed=5288820;
RA   Charache S., Ostertag W., von Ehrenstein G.;
RT   "Clinical studies and physiological properties of Hopkins-2
RT   haemoglobin.";
RL   Nature New Biol. 234:248-251(1971).
RN   [36]
RP   VARIANT DENMARK HILL ALA-96.
RX   PubMed=5085669;
RA   Wiltshire B.G., Clark K.G., Lorkin P.A., Lehmann H.;
RT   "Haemoglobin Denmark Hill 95 (G2) Pro-Ala, a variant with unusual
RT   electrophoretic and oxygen-binding properties.";
RL   Biochim. Biophys. Acta 278:459-464(1972).
RN   [37]
RP   VARIANT SETIF TYR-95.
RX   PubMed=4667378; DOI=10.1016/0014-5793(72)80645-8;
RA   Wajcman H., Belkhodja O., Labie D.;
RT   "Hb Setif: G1 (94) Asp-Tyr. A new chain hemoglobin variant with
RT   substitution of the residue involved in hydrogen bond between unlike
RT   subunits.";
RL   FEBS Lett. 27:298-300(1972).
RN   [38]
RP   VARIANT ANN ARBOR ARG-81.
RX   PubMed=5033650; DOI=10.1126/science.176.4042.1427;
RA   Adams J.G. III, Winter W.P., Rucknagel D.L., Spencer H.H.;
RT   "Biosynthesis of hemoglobin Ann Arbor: evidence for catabolic and
RT   feedback regulation.";
RL   Science 176:1427-1429(1972).
RN   [39]
RP   VARIANT SAWARA ALA-7.
RX   PubMed=4744335;
RA   Sumida I., Ohta Y., Imamura T., Yanase T.;
RT   "Hemoglobin Sawara: alpha 6(A4) aspartic acid leads to alanine.";
RL   Biochim. Biophys. Acta 322:23-26(1973).
RN   [40]
RP   VARIANT M-BOSTON/M-OSAKA TYR-59.
RX   PubMed=4521212; DOI=10.1073/pnas.70.12.3870;
RA   Pulsinelli P.D., Perutz M.F., Nagel R.L.;
RT   "Structure of hemoglobin M Boston, a variant with a five-coordinated
RT   ferric heme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 70:3870-3874(1973).
RN   [41]
RP   VARIANT J-ROVIGO ASP-54.
RX   PubMed=4824923;
RA   Alberti R., Mariuzzi G.M., Artibani L., Bruni E., Tentori L.;
RT   "A new haemoglobin variant: J-Rovigo alpha 53 (E-2) alanine leads to
RT   aspartic acid.";
RL   Biochim. Biophys. Acta 342:1-4(1974).
RN   [42]
RP   VARIANT HIROSAKI LEU-44.
RX   PubMed=1182166;
RA   Ohba Y., Miyaji T., Matsuoka M., Yokoyama M., Numakura H.;
RT   "Hemoglobin Hirosaki (alpha 43 [CE 1] Phe replaced by Leu), a new
RT   unstable variant.";
RL   Biochim. Biophys. Acta 405:155-160(1975).
RN   [43]
RP   VARIANT PONTOISE ASP-64.
RX   PubMed=849454; DOI=10.1016/0005-2795(77)90036-8;
RA   Thillet J., Blouquit Y., Perrone F., Rosa J.;
RT   "Hemoglobin Pontoise alpha63 Ala replaced by Asp(E12). A new fast
RT   moving variant.";
RL   Biochim. Biophys. Acta 491:16-22(1977).
RN   [44]
RP   CHARACTERIZATION OF VARIANT SAWARA ALA-7.
RX   PubMed=20980; DOI=10.1016/0005-2795(77)90253-7;
RA   Sasaki J., Imamura T., Sumida I., Yanase T., Ohya M.;
RT   "Increased oxygen affinity for hemoglobin Sawara: alphaA4(6) aspartic
RT   acid replaced by alanine.";
RL   Biochim. Biophys. Acta 495:183-186(1977).
RN   [45]
RP   VARIANT PORT PHILLIP PRO-92.
RX   PubMed=902765; DOI=10.1016/0014-5793(77)80940-X;
RA   Brennan S.O., Tauro G.P., Melrose W.;
RT   "Haemoglobin Port Phillip alpha91 (FG3) Leu replaced by Pro, a new
RT   unstable haemoglobin.";
RL   FEBS Lett. 81:115-117(1977).
RN   [46]
RP   VARIANT MOABIT ARG-87.
RX   PubMed=108887;
RA   Knuth A., Pribilla W., Marti H.R., Winterhalter K.H.;
RT   "Hemoglobin Moabit: alpha 86 (F7) Leu leads to Arg: a new unstable
RT   abnormal hemoglobin.";
RL   Acta Haematol. 61:121-124(1979).
RN   [47]
RP   VARIANT PRATO SER-32.
RX   PubMed=486536; DOI=10.1016/0005-2795(79)90184-3;
RA   Marinucci M., Mavilio F., Massa A., Gabbianelli M., Fontanarosa P.P.,
RA   Camagna A., Ignesti C., Tentori L.;
RT   "A new abnormal human hemoglobin: Hb Prato (alpha 2 31 (B12) Arg leads
RT   to Ser beta 2).";
RL   Biochim. Biophys. Acta 578:534-540(1979).
RN   [48]
RP   VARIANT DUNN ASN-7.
RX   PubMed=478975; DOI=10.3109/03630267908998909;
RA   Jue D.L., Johnson M.H., Patchen L.C., Moo-Penn W.F.;
RT   "Hemoglobin Dunn: alpha 6 (A4) aspartic acid replaced by asparagine.";
RL   Hemoglobin 3:137-143(1979).
RN   [49]
RP   CHARACTERIZATION OF VARIANT DUNN ASN-7.
RX   PubMed=7435503; DOI=10.1002/ajh.2830090203;
RA   Charache S., Brimhall B., Zaatari G.;
RT   "Oxygen affinity and stability of hemoglobin Dunn alpha 6(A4)Asp
RT   replaced by Asn): use of isoelectric focusing in recognition of a new
RT   abnormal hemoglobin.";
RL   Am. J. Hematol. 9:151-160(1980).
RN   [50]
RP   VARIANT MILLEDGEVILLE LEU-45.
RX   PubMed=7213661; DOI=10.1016/0005-2795(80)90138-5;
RA   Honig G.R., Vida L.N., Shamsuddin M., Mason R.G., Schlumpf H.W.,
RA   Luke R.A.;
RT   "Hemoglobin Milledgeville (alpha 44 (CD2) Pro leads to Leu): a new
RT   variant with increased oxygen affinity.";
RL   Biochim. Biophys. Acta 626:424-431(1980).
RN   [51]
RP   VARIANT LEGNANO LEU-142.
RX   PubMed=7462179;
RA   Giuliani A., Maffi D., Cappabianca M.P., Tentori L.;
RT   "Hemoglobin Legnano (alpha 2 141 (HC3) Arg leads to Leu beta2) a new
RT   high oxygen affinity variant. Functional and structural studies.";
RL   J. Biochem. 88:1233-1237(1980).
RN   [52]
RP   VARIANT SURESNES HIS-142.
RX   PubMed=7410435;
RA   Poyart C., Bursaux E., Arnone A., Bonaventura J., Bonaventura C.;
RT   "Structural and functional studies of hemoglobin Suresnes (arg 141
RT   alpha 2 replaced by His beta 2). Consequences of disrupting an oxygen-
RT   linked anion-binding site.";
RL   J. Biol. Chem. 255:9465-9473(1980).
RN   [53]
RP   VARIANT FERNDOWN VAL-7.
RX   PubMed=7238857; DOI=10.1016/0014-5793(81)81047-2;
RA   Lee-Potter J.P., Deacon-Smith R.A., Lehmann H., Robb L.;
RT   "Haemoglobin Ferndown (alpha 6 [A4] aspartic acid replaced by
RT   valine).";
RL   FEBS Lett. 126:117-119(1981).
RN   [54]
RP   VARIANT TOTTORI VAL-60.
RX   PubMed=7275660; DOI=10.3109/03630268108991818;
RA   Nakatsuji T., Miwa S., Ohba Y., Miyaji T., Matsumoto N., Matsuoka I.;
RT   "Hemoglobin Tottori (alpha 59[E8] glycine replaced by valine).";
RL   Hemoglobin 5:427-439(1981).
RN   [55]
RP   VARIANT KAWACHI ARG-45.
RX   PubMed=7068434; DOI=10.3109/03630268208996932;
RA   Harano T., Harano K., Ueda S., Shibata S., Imai K., Ohba Y.,
RA   Shinohara T., Horio S., Nishioka K., Shirotani H.;
RT   "Hemoglobin Kawachi [alpha 44 (CE2) Pro leads to Arg]: a new
RT   hemoglobin variant of high oxygen affinity with amino acid
RT   substitution at alpha 1 beta 2 contact.";
RL   Hemoglobin 6:43-49(1982).
RN   [56]
RP   VARIANT KOKURA GLY-48.
RX   PubMed=7068437; DOI=10.3109/03630268208996936;
RA   Ohba Y., Hattori Y., Matsuoka M., Miyaji T., Fuyuno K.;
RT   "HB Kokura [alpha 47 (CE 5) Asp leads to Gly]: a slightly unstable
RT   variant.";
RL   Hemoglobin 6:69-74(1982).
RN   [57]
RP   VARIANT EVANSTON ARG-15.
RX   PubMed=6882779; DOI=10.1016/0167-4838(83)90122-X;
RA   Moo-Penn W.F., Baine R.M., Jue D.L., Johnson M.H., McGuffey J.E.,
RA   Benson J.M.;
RT   "Hemoglobin Evanston: alpha 14(A12) Trp leads to Arg. A variant
RT   hemoglobin associated with alpha-thalassemia-2.";
RL   Biochim. Biophys. Acta 747:65-70(1983).
RN   [58]
RP   VARIANT TOKONAME THR-140.
RX   PubMed=6188720; DOI=10.3109/03630268309038404;
RA   Harano T., Harano K., Shibata S., Ueda S., Imai K., Seki M.;
RT   "Hemoglobin Tokoname [alpha 139 (HC 1) Lys leads to Thr]: a new
RT   hemoglobin variant with a slightly increased oxygen affinity.";
RL   Hemoglobin 7:85-90(1983).
RN   [59]
RP   VARIANT IWATA ARG-88.
RX   PubMed=6874376;
RA   Liu G.Y., Zhang G.X., Nie S.Y., Luo H.Y., Teng Y.Q., Liu S.P.,
RA   Song M., Son L., Chen S.S., Jia P.C., Liang C.C.;
RT   "A case of hemoglobin Iwata [alpha 87(F8)His leads to Arg] in China.";
RL   Hemoglobin 7:279-282(1983).
RN   [60]
RP   VARIANT ETOBICOKE ARG-85.
RX   PubMed=6874377; DOI=10.3109/03630268309048660;
RA   Headlee M.G., Nakatsuji T., Lam H., Wrightstone R.N., Huisman T.H.;
RT   "Hb Etobicoke, alpha 85(F5) Ser leads to Arg found in a newborn of
RT   French-Indian-English descent.";
RL   Hemoglobin 7:285-287(1983).
RN   [61]
RP   VARIANT AICHI ARG-51.
RX   PubMed=6714429; DOI=10.1016/0014-5793(84)80337-3;
RA   Harano T., Harano K., Shibata S., Ueda S., Mori H., Seki M.;
RT   "Hemoglobin Aichi [alpha 50(CE8) His----Arg]: a new slightly unstable
RT   hemoglobin variant discovered in Japan.";
RL   FEBS Lett. 169:297-299(1984).
RN   [62]
RP   VARIANT CORDELE ALA-48.
RX   PubMed=6547117; DOI=10.3109/03630268408996959;
RA   Nakatsuji T., Wilson J.B., Huisman T.H.;
RT   "Hb Cordele alpha(2)47 (CE5)Asp----Ala beta 2. A mildly unstable
RT   variant observed in black twins.";
RL   Hemoglobin 8:37-46(1984).
RN   [63]
RP   VARIANT MANITOBA ARG-103, AND VARIANT CONTALDO ARG-104.
RX   PubMed=6547932; DOI=10.3109/03630268408991710;
RA   Sciarratta G.V., Ivaldi G., Molaro G.L., Sansone G., Salkie M.L.,
RA   Wilson J.B., Reese A.L., Huisman T.H.;
RT   "The characterization of hemoglobin Manitoba or alpha
RT   (2)102(G9)Ser----Arg beta 2 and hemoglobin Contaldo or alpha
RT   (2)103(G10)His----Arg beta 2 by high performance liquid
RT   chromatography.";
RL   Hemoglobin 8:169-181(1984).
RN   [64]
RP   CHARACTERIZATION OF VARIANT EVANSTON ARG-15.
RX   PubMed=6725558; DOI=10.1172/JCI111382;
RA   Honig G.R., Shamsuddin M., Vida L.N., Mompoint M., Valcourt E.,
RA   Bowie L.J., Jones E.C., Powers P.A., Spritz R.A., Guis M.;
RT   "Hemoglobin Evanston (alpha 14 Trp----Arg). An unstable alpha-chain
RT   variant expressed as alpha-thalassemia.";
RL   J. Clin. Invest. 73:1740-1749(1984).
RN   [65]
RP   VARIANT NUNOBIKI CYS-142.
RX   PubMed=3973024; DOI=10.1172/JCI111749;
RA   Shimasaki S.;
RT   "A new hemoglobin variant, hemoglobin Nunobiki [alpha 141 (HC3)
RT   Arg----Cys]. Notable influence of the carboxy-terminal cysteine upon
RT   various physico-chemical characteristics of hemoglobin.";
RL   J. Clin. Invest. 75:695-701(1985).
RN   [66]
RP   VARIANT LOIRE SER-89.
RX   PubMed=3142772; DOI=10.1111/j.1432-1033.1988.tb14377.x;
RA   Baklouti F., Baudin-Chich V., Kister J., Marden M., Teyssier G.,
RA   Poyart C., Delaunay J., Wajcman H.;
RT   "Increased oxygen affinity with normal heterotropic effects in
RT   hemoglobin Loire [alpha 88(F9)Ala----Ser].";
RL   Eur. J. Biochem. 177:307-312(1988).
RN   [67]
RP   VARIANT LUXEMBOURG HIS-25.
RX   PubMed=2599879; DOI=10.3109/03630268908998082;
RA   Groff P., Galacteros F., Kalmes G., Blouquit Y., Wajcman H.;
RT   "Hb Luxembourg [alpha 24(B5) Tyr----His]: a new unstable variant.";
RL   Hemoglobin 13:429-436(1989).
RN   [68]
RP   VARIANT MIYANO SER-42.
RX   PubMed=2634665; DOI=10.3109/03630268908998841;
RA   Ohba Y., Imai K., Uenaka R., Ami M., Fujisawa K., Itoh K.,
RA   Hirakawa K., Miyaji T.;
RT   "Hb Miyano or alpha 41(C6)Thr----Ser: a new high oxygen affinity alpha
RT   chain variant found in an erythremic blood donor.";
RL   Hemoglobin 13:637-647(1989).
RN   [69]
RP   VARIANT REIMS GLY-24.
RX   PubMed=2634669; DOI=10.3109/03630268908998846;
RA   Bardakdjian-Michau J., Rosa J., Galacteros F., Lancelot M.,
RA   Marquart F.X.;
RT   "Hb Reims [alpha 2(23)(B4)Glu----Gly beta 2]: a new alpha chain
RT   variant with slightly decreased stability.";
RL   Hemoglobin 13:733-735(1989).
RN   [70]
RP   VARIANT ATTLEBORO PRO-139.
RX   PubMed=2108715; DOI=10.1021/bi00453a023;
RA   McDonald M.J., Michalski L.A., Turci S.M., Guillette R.A., Jue D.L.,
RA   Johnson M.H., Moo-Penn W.F.;
RT   "Structural, functional, and subunit assembly properties of hemoglobin
RT   Attleboro [alpha 138 (H21) Ser----Pro], a variant possessing a site
RT   maturation at a critical C-terminal residue.";
RL   Biochemistry 29:173-178(1990).
RN   [71]
RP   VARIANT FUKUTOMI VAL-127.
RX   PubMed=2079432; DOI=10.3109/03630269009005803;
RA   Hidaka K., Iuchi I., Kobayashi T., Katoh K., Yaguchi K.;
RT   "Hb Fukutomi [alpha 126(H9)Asp----Val]: a new hemoglobin variant with
RT   high oxygen affinity.";
RL   Hemoglobin 14:499-509(1990).
RN   [72]
RP   VARIANT DALLAS LYS-98.
RX   PubMed=1390940; DOI=10.1016/0925-4439(92)90021-E;
RA   Lendaro E., Ippoliti R., Brancaccio A., Bellelli A., Vallone B.,
RA   Ivaldi G., Sciarratta G.V., Castello C., Tomova S., Brunori M.;
RT   "Hemoglobin Dallas (alpha 97(G4)Asn-->Lys): functional
RT   characterization of a high oxygen affinity natural mutant.";
RL   Biochim. Biophys. Acta 1180:15-20(1992).
RN   [73]
RP   VARIANT ROUEN/ETHIOPIA HIS-141.
RX   PubMed=1390944; DOI=10.1016/0925-4439(92)90026-J;
RA   Wajcman H., Kister J., Marden M., Lahary A., Monconduit M.,
RA   Galacteros F.;
RT   "Hemoglobin Rouen (alpha-140 (HC2) Tyr-->His): alteration of the
RT   alpha-chain C-terminal region and moderate increase in oxygen
RT   affinity.";
RL   Biochim. Biophys. Acta 1180:53-57(1992).
RN   [74]
RP   VARIANT AL-AIN ABU DHABI ASP-19.
RX   PubMed=1428941; DOI=10.3109/03630269209005687;
RA   Abbes S., M'Rad A., Fitzgerald P.A., Dormer P., Blouquit Y.,
RA   Kister J., Galacteros F., Wajcman H.;
RT   "HB Al-Ain Abu Dhabi [alpha 18(A16)Gly-->Asp]: a new hemoglobin
RT   variant discovered in an Emiratee family.";
RL   Hemoglobin 16:355-362(1992).
RN   [75]
RP   VARIANT QUESTEMBERT PRO-132.
RX   PubMed=8493987; DOI=10.1002/ajh.2830420407;
RA   Wajcman H., Vasseur C., Blouquit Y., Rosa J., Labie D., Najman A.,
RA   Reman O., Leporrier M., Galacteros F.;
RT   "Unstable alpha-chain hemoglobin variants with factitious beta-
RT   thalassemia biosynthetic ratio: Hb Questembert (alpha
RT   131[H14]Ser-->Pro) and Hb Caen (alpha 132[H15]Val-->Gly).";
RL   Am. J. Hematol. 42:367-374(1993).
RN   [76]
RP   VARIANT ADANA ASP-60.
RX   PubMed=8237999; DOI=10.1002/ajh.2830440410;
RA   Cueruek M.A., Dimovski A.J., Baysal E., Gu L.H., Kutlar F.,
RA   Molchanova T.P., Webber B.B., Altay C., Guergey A., Huisman T.H.;
RT   "Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable
RT   alpha 1-globin variant, observed in combination with the -(alpha)20.5
RT   Kb alpha-thal-1 deletion in two Turkish patients.";
RL   Am. J. Hematol. 44:270-275(1993).
RN   [77]
RP   VARIANT MONTEFIORE TYR-127.
RX   PubMed=8798486; DOI=10.1074/jbc.271.38.22990;
RA   Wajcman H., Kister J., Galacteros F., Spielvogel A., Lin M.J.,
RA   Vidugiris G.J., Hirsch R.E., Friedman J.M., Nagel R.L.;
RT   "Hb Montefiore (126(H9)Asp-->Tyr). High oxygen affinity and loss of
RT   cooperativity secondary to C-terminal disruption.";
RL   J. Biol. Chem. 271:22990-22998(1996).
RN   [78]
RP   VARIANT ATAGO TYR-86.
RX   PubMed=5115619;
RA   Fujiwara N., Maekawa T., Matsuda G.;
RT   "Hemoglobin Atago (alpha2-85 Tyr beta-2) a new abnormal human
RT   hemoglobin found in Nagasaki. Biochemical studies on hemoglobins and
RT   myoglobins. VI.";
RL   Int. J. Protein Res. 3:35-39(1971).
RN   [79]
RP   VARIANT AUCKLAND ASN-88.
RX   PubMed=9322075; DOI=10.3109/03630269708993126;
RA   Brennan S.O., Matthews J.R.;
RT   "Hb Auckland [alpha 87(F8) His-->Asn]: a new mutation of the proximal
RT   histidine identified by electrospray mass spectrometry.";
RL   Hemoglobin 21:393-403(1997).
RN   [80]
RP   VARIANTS J-BUDA ASN-62 AND G-PEST ASN-75.
RA   Brimhall B.J., Duerst M., Hollan S.R., Stenzel P., Szelenyi J.,
RA   Jones R.T.;
RT   "Structural characterizations of hemoglobins J-Buda (alpha 61 (E10)
RT   Lys-to-Asn) and G-Pest (alpha 74 (EF3) Asp-to-Asn).";
RL   Biochim. Biophys. Acta 336:344-360(1974).
RN   [81]
RP   VARIANT CEMENELUM TRP-93.
RX   PubMed=8148419; DOI=10.1007/BF01715134;
RA   Wajcman H., Kister J., M'Rad A., Soummer A.M., Galacteros F.;
RT   "Hb Cemenelum [alpha 92 (FG4) Arg-->Trp]: a hemoglobin variant of the
RT   alpha 1/beta 2 interface that displays a moderate increase in oxygen
RT   affinity.";
RL   Ann. Hematol. 68:73-76(1994).
RN   [82]
RP   VARIANTS CHONGQING ARG-3 AND HARBIN MET-17.
RX   PubMed=6526652; DOI=10.3109/03630268408991742;
RA   Zeng Y.-T., Huang S.-Z., Qiu X.-K., Cheng G.-C., Ren Z.-R., Jin Q.-C.,
RA   Chen C.-Y., Jiao C.-T., Tang Z.-G., Liu R.-H., Bao X.-H., Zeng L.-Z.,
RA   Duan Y.-Q., Zhang G.-Y.;
RT   "Hemoglobin Chongqing [alpha 2(NA2)Leu-->Arg] and hemoglobin Harbin
RT   [alpha 16(A14)Lys-->Met] found in China.";
RL   Hemoglobin 8:569-581(1984).
RN   [83]
RP   VARIANT CLINIC LYS-61 DEL.
RX   PubMed=10206681;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:5<412::AID-HUMU14>3.0.CO;2-R;
RA   Ayala S., Colomer D., Gelpi J.L., Corron J.L.V.;
RT   "Alpha-thalassaemia due to a single codon deletion in the alpha 1-
RT   globin gene. Computational structural analysis of the new alpha-chain
RT   variant.";
RL   Hum. Mutat. 11:412-412(1998).
RN   [84]
RP   VARIANT DAVENPORT HIS-79.
RX   PubMed=2101836; DOI=10.3109/03630269009046968;
RA   Wilson J.B., Webber B.B., Plaseska D., de Alarcon P.A., McMillan S.K.,
RA   Huisman T.H.J.;
RT   "Hb Davenport or alpha 2(78)(EF7)Asn-->His beta 2.";
RL   Hemoglobin 14:599-605(1990).
RN   [85]
RP   VARIANT EVANS MET-63.
RX   PubMed=2606724; DOI=10.3109/03630268908993106;
RA   Wilson J.B., Webber B.B., Kutlar A., Reese A.L., McKie V.C.,
RA   Lutcher C.L., Felice A.E., Huisman T.H.J.;
RT   "Hb Evans or alpha 262(E11)Val-->Met beta 2; an unstable hemoglobin
RT   causing a mild hemolytic anemia.";
RL   Hemoglobin 13:557-566(1989).
RN   [86]
RP   VARIANTS SPANISH TOWN VAL-28 AND FORT DE FRANCE ARG-46.
RX   PubMed=2752146;
RA   Cash F.E., Monplaisir N., Goossens M., Liebhaber S.A.;
RT   "Locus assignment of two alpha-globin structural mutants from the
RT   Caribbean basin: alpha Fort de France (alpha 45 Arg) and alpha Spanish
RT   Town (alpha 27 Val).";
RL   Blood 74:833-835(1989).
RN   [87]
RP   VARIANT GODAVARI THR-96.
RX   PubMed=9494044; DOI=10.3109/03630269809071513;
RA   Wajcman H., Kister J., Riou J., Galacteros F., Girot R.,
RA   Maier-Redelsperger M., Nayudu N.V.S., Giordano P.C.;
RT   "Hb Godavari [alpha 95(G2)Pro-->Thr]: a neutral amino acid
RT   substitution in the alpha 1 beta 2 interface that modifies the
RT   electrophoretic mobility of hemoglobin.";
RL   Hemoglobin 22:11-22(1998).
RN   [88]
RP   VARIANT GRADY GLU-PHE-THR-119 INS.
RX   PubMed=4528583; DOI=10.1073/pnas.71.8.3270;
RA   Huisman T.H.J., Wilson J.B., Gravely M., Hubbard M.;
RT   "Hemoglobin Grady: the first example of a variant with elongated
RT   chains due to an insertion of residues.";
RL   Proc. Natl. Acad. Sci. U.S.A. 71:3270-3273(1974).
RN   [89]
RP   VARIANT HANAMAKI GLU-140.
RX   PubMed=1634363; DOI=10.3109/03630269209005677;
RA   Orisaka M., Tajima T., Harano T., Harano K., Kushida Y., Imai K.;
RT   "A new alpha chain variant, Hb Hanamaki or alpha 2(139)(HC1)Lys-->Glu
RT   beta 2, found in a Japanese family.";
RL   Hemoglobin 16:67-71(1992).
RN   [90]
RP   VARIANT HANDA MET-91.
RX   PubMed=6815131; DOI=10.3109/03630268208996943;
RA   Harano T., Harano K., Shibata S., Ueda S., Imai K., Seki M.;
RT   "HB Handa [alpha 90 (FG 2) Lys replaced by Met]: structure and
RT   biosynthesis of a new slightly higher oxygen affinity variant.";
RL   Hemoglobin 6:379-389(1982).
RN   [91]
RP   VARIANT HASHARON HIS-48.
RX   PubMed=5780195; DOI=10.1172/JCI106041;
RA   Charache S., Mondzac A.M., Gessner U.;
RT   "Hemoglobin Hasharon (alpha-2-47 his(CD5)beta-2): a hemoglobin found
RT   in low concentration.";
RL   J. Clin. Invest. 48:834-847(1969).
RN   [92]
RP   VARIANT HOBART ARG-21.
RX   PubMed=3654264; DOI=10.3109/03630268709017887;
RA   Fleming P.J., Sumner D.R., Wyatt K., Hughes W.G., Melrose W.D.,
RA   Jupe D.M.D., Baikie M.J.;
RT   "Hemoglobin Hobart or alpha 20(Bl)His-->Arg: a new alpha chain
RT   hemoglobin variant.";
RL   Hemoglobin 11:211-220(1987).
RN   [93]
RP   VARIANT INKSTER VAL-86.
RX   PubMed=4212045; DOI=10.1111/j.1365-2141.1974.tb00489.x;
RA   Reed R.E., Winter W.P., Rucknagel D.L.;
RT   "Haemoglobin Inkster (alpha2 85aspartic acid leads to valine beta2)
RT   coexisting with beta-thalassaemia in a Caucasian family.";
RL   Br. J. Haematol. 26:475-484(1974).
RN   [94]
RP   VARIANT KANAGAWA MET-41.
RX   PubMed=1634355; DOI=10.3109/03630269209005670;
RA   Miyashita H., Hashimoto K., Mohri H., Ohokubo T., Harano T.,
RA   Harano K., Imai K.;
RT   "Hb Kanagawa [alpha 40(C5)Lys-->Met]: a new alpha chain variant with
RT   an increased oxygen affinity.";
RL   Hemoglobin 16:1-10(1992).
RN   [95]
RP   VARIANT KURDISTAN TYR-48.
RX   PubMed=8195005; DOI=10.3109/03630269409014141;
RA   Giordano P.C., Harteveld C.L., Streng H., Oosterwijk J.C.,
RA   Heister J.G.A.M., Amons R., Bernini L.F.;
RT   "Hb Kurdistan [alpha 47(CE5)Asp-->Tyr], a new alpha chain variant in
RT   combination with beta (0)-thalassemia.";
RL   Hemoglobin 18:11-18(1994).
RN   [96]
RP   VARIANT KUROSAKI GLU-8.
RX   PubMed=7558876; DOI=10.3109/03630269509036940;
RA   Harano T., Harano K., Imai K., Murakami T., Matsubara H.;
RT   "Hb Kurosaki [alpha 7(A5)Lys-->Glu]: a new alpha chain variant found
RT   in a Japanese woman.";
RL   Hemoglobin 19:197-201(1995).
RN   [97]
RP   VARIANT J-MEERUT/J-BIRMINGHAM GLU-121.
RX   PubMed=7713747; DOI=10.3109/03630269409045775;
RA   Yalcin A., Avcu F., Beyan C., Guergey A., Ural A.U.;
RT   "A case of HB J-Meerut (or Hb J-Birmingham) [alpha
RT   120(H3)Ala-->Glu].";
RL   Hemoglobin 18:433-435(1994).
RN   [98]
RP   VARIANT MELUSINE SER-115.
RX   PubMed=8294199; DOI=10.3109/03630269308997494;
RA   Wacjman H., Klames G., Groff P., Prome D., Riou J., Galacteros F.;
RT   "Hb Melusine [alpha 114(GH2)Pro-->Ser]: a new neutral hemoglobin
RT   variant.";
RL   Hemoglobin 17:397-405(1993).
RN   [99]
RP   VARIANT MONTGOMERY ARG-49.
RX   PubMed=1115799;
RA   Brimhall B., Jones R.T., Schneider R.G., Hosty T.S., Tomlin G.,
RA   Atkins R.;
RT   "Two new hemoglobins. Hemoglobin Alabama (beta39(C5)Gln leads to Lys)
RT   and hemoglobin Montgomery (alpha 48(CD 6) Leu leads to Arg).";
RL   Biochim. Biophys. Acta 379:28-32(1975).
RN   [100]
RP   VARIANT PETAH TIKVA ASP-111.
RX   PubMed=7470621;
RA   Honig G.R., Shamsuddin M., Zaizov R., Steinherz M., Solar I.,
RA   Kirschman C.;
RT   "Hemoglobin Petah Tikva (alpha 110 Ala replaced by Asp): a new
RT   unstable variant with alpha-thalassemia-like expression.";
RL   Blood 57:705-711(1981).
RN   [101]
RP   VARIANT PHNOM PENH ILE-118 INS.
RX   PubMed=9452028;
RA   Wajcman H., Prehu M.O., Prehu C., Blouquit Y., Prome D.,
RA   Galacteros F.;
RT   "Hemoglobin Phnom Penh [alpha117Phe(H1)-Ile-alpha118Thr(H2)]; evidence
RT   for a hotspot for insertion of residues in the third exon of the
RT   alpha1-globin gene.";
RL   Hum. Mutat. Suppl. 1:S20-S22(1998).
RN   [102]
RP   VARIANT PORT HURON ARG-57.
RX   PubMed=1802882; DOI=10.3109/03630269108998858;
RA   Zwerdling T., Williams S., Nasr S.A., Rucknagel D.L.;
RT   "Hb Port Huron [alpha 56 (E5)Lys-->Arg]: a new alpha chain variant.";
RL   Hemoglobin 15:381-391(1991).
RN   [103]
RP   VARIANT SHENYANG GLU-27.
RX   PubMed=7161109;
RA   Zeng Y.-T., Huang S.-Z., Zhou X., Qiu X.-K., Dong Q., Li M., Bai J.;
RT   "Hb Shenyang (alpha 26 (B7) Ala replaced by Glu): a new unstable
RT   variant found in China.";
RL   Hemoglobin 6:625-628(1982).
RN   [104]
RP   VARIANT SUAN-DOK ARG-110.
RX   PubMed=478977; DOI=10.3109/03630267908998911;
RA   Sanguansermsri T., Matragoon S., Changloah L., Flatz G.;
RT   "Hemoglobin Suan-Dok (alpha 2 109 (G16) Leu replaced by Arg beta 2):
RT   an unstable variant associated with alpha-thalassemia.";
RL   Hemoglobin 3:161-174(1979).
RN   [105]
RP   INVOLVEMENT IN HEIBAN, AND VARIANT TOYAMA ARG-137.
RX   PubMed=2833478; DOI=10.3109/03630268709027870;
RA   Ohba Y., Yamamoto K., Hattori Y., Kawata R., Miyaji T.;
RT   "Hyperunstable hemoglobin Toyama [alpha 2 136(H19)Leu----Arg beta 2]:
RT   detection and identification by in vitro biosynthesis with radioactive
RT   amino acids.";
RL   Hemoglobin 11:539-556(1987).
RN   [106]
RP   VARIANT SUN PRAIRIE PRO-131.
RX   PubMed=2079430; DOI=10.3109/03630269009005801;
RA   Harkness M., Harkness D.R., Kutlar F., Kutlar A., Wilson J.B.,
RA   Webber B.B., Codrington J.F., Huisman T.H.J.;
RT   "Hb Sun Prairie or alpha(2)130(H13)Ala-->Pro beta 2, a new unstable
RT   variant occurring in low quantities.";
RL   Hemoglobin 14:479-489(1990).
RN   [107]
RP   VARIANT SWAN RIVER GLY-7.
RX   PubMed=8745434; DOI=10.3109/03630269609027912;
RA   Harano T., Harano K., Imai K., Terunuma S.;
RT   "HB Swan River [alpha 6(A4)Asp-->Gly] observed in a Japanese man.";
RL   Hemoglobin 20:75-78(1996).
RN   [108]
RP   VARIANT THIONVILLE GLU-2.
RX   PubMed=1618774;
RA   Vasseur C., Blouquit Y., Kister J., Prome D., Kavanaugh J.S.,
RA   Rogers P.H., Guillemin C., Arnone A., Galacteros F., Poyart C.,
RA   Rosa J., Wajcman H.;
RT   "Hemoglobin Thionville. An alpha-chain variant with a substitution of
RT   a glutamate for valine at NA-1 and having an acetylated methionine NH2
RT   terminus.";
RL   J. Biol. Chem. 267:12682-12691(1992).
RN   [109]
RP   VARIANT TUNIS-BIZERTE PRO-130.
RX   PubMed=7786798; DOI=10.1111/j.1365-2141.1995.tb03382.x;
RA   Darbellay R., Mach-Pascual S., Rose K., Graf J., Beris P.;
RT   "Haemoglobin Tunis-Bizerte: a new alpha 1 globin 129 Leu-->Pro
RT   unstable variant with thalassaemic phenotype.";
RL   Br. J. Haematol. 90:71-76(1995).
RN   [110]
RP   VARIANT TURRIFF GLU-100.
RX   PubMed=1634357; DOI=10.3109/03630269209005671;
RA   Langdown J.V., Davidson R.J., Williamson D.;
RT   "A new alpha chain variant, Hb Turriff [alpha 99(G6)Lys-->Glu]: the
RT   interference of abnormal hemoglobins in Hb A1c determination.";
RL   Hemoglobin 16:11-17(1992).
RN   [111]
RP   VARIANT VAL DE MARNE ARG-134.
RX   PubMed=8294200; DOI=10.3109/03630269308997495;
RA   Wacjman H., Kister J., M'Rad A., Marden M.C., Riou J., Galacteros F.;
RT   "Hb Val de Marne [alpha 133(H16)Ser-->Arg]: a new hemoglobin variant
RT   with moderate increase in oxygen affinity.";
RL   Hemoglobin 17:407-417(1993).
RN   [112]
RP   VARIANT WESTMEAD GLN-123.
RX   PubMed=1686260; DOI=10.3109/03630269109027881;
RA   Jiang N.H., Liang S., Wen X.J., Liang R., Su C., Tang Z.;
RT   "Hb Westmead: an alpha 2-globin gene mutation detected by polymerase
RT   chain reaction and Stu I cleavage.";
RL   Hemoglobin 15:291-295(1991).
RN   [113]
RP   VARIANT WOODVILLE TYR-7.
RX   PubMed=3754246; DOI=10.3109/03630268609046440;
RA   Como P.F., Barber S., Sage R.E., Kronenberg H.;
RT   "Hemoglobin Woodville: alpha (2)6(A4) aspartic acid-->tyrosine.";
RL   Hemoglobin 10:135-141(1986).
RN   [114]
RP   VARIANT YUDA ASP-131.
RX   PubMed=1428950; DOI=10.3109/03630269209005698;
RA   Fujisawa K., Hattori Y., Ohba Y., Ando S.;
RT   "Hb Yuda or alpha 130(H13)Ala-->Asp; a new alpha chain variant with
RT   low oxygen affinity.";
RL   Hemoglobin 16:435-439(1992).
RN   [115]
RP   VARIANT ZAIRE HIS-LEU-PRO-ALA-GLU-117 INS.
RX   PubMed=1511986; DOI=10.1007/BF00221961;
RA   Wajcman H., Blouquit Y., Vasseur C., le Querrec A., Laniece M.,
RA   Melevendi C., Rasore A., Galacteros F.;
RT   "Two new human hemoglobin variants caused by unusual mutational
RT   events: Hb Zaire contains a five residue repetition within the alpha-
RT   chain and Hb Duino has two residues substituted in the beta-chain.";
RL   Hum. Genet. 89:676-680(1992).
RN   [116]
RP   VARIANT HBH VAL-63 DEL.
RX   PubMed=10569720; DOI=10.3109/03630269909090747;
RA   Traeger-Synodinos J., Harteveld C.L., Kanavakis E., Giordano P.C.,
RA   Kattamis C., Bernini L.F.;
RT   "Hb Aghia Sophia [alpha62(E11)Val-->0 (alpha1)], an 'in-frame'
RT   deletion causing alpha-thalassemia.";
RL   Hemoglobin 23:317-324(1999).
RN   [117]
RP   VARIANT BOGHE GLN-59, AND VARIANT CHAROLLES TYR-104.
RX   PubMed=10569723; DOI=10.3109/03630269909090750;
RA   Lacan P., Francina A., Souillet G., Aubry M., Couprie N.,
RA   Dementhon L., Becchi M.;
RT   "Two new alpha chain variants: Hb Boghe [alpha58(E7)His-->Gln,
RT   alpha2], a variant on the distal histidine, and Hb Charolles
RT   [alpha103(G10)His-Tyr, alpha1].";
RL   Hemoglobin 23:345-352(1999).
RN   [118]
RP   VARIANT CAMPINAS VAL-27, AND VARIANT WEST ONE GLY-127.
RX   PubMed=14576901; DOI=10.1590/S0100-879X2003001100004;
RA   Jorge S.B., Melo M.B., Costa F.F., Sonati M.F.;
RT   "Screening for mutations in human alpha-globin genes by nonradioactive
RT   single-strand conformation polymorphism.";
RL   Braz. J. Med. Biol. Res. 36:1471-1474(2003).
RN   [119]
RP   VARIANT BASSETT ALA-95, AND CHARACTERIZATION OF VARIANT BASSETT
RP   ALA-95.
RX   PubMed=15495251; DOI=10.1002/ajh.20184;
RA   Abdulmalik O., Safo M.K., Lerner N.B., Ochotorena J., Daikhin E.,
RA   Lakka V., Santacroce R., Abraham D.J., Asakura T.;
RT   "Characterization of hemoglobin Bassett (alpha94Asp-->Ala), a variant
RT   with very low oxygen affinity.";
RL   Am. J. Hematol. 77:268-276(2004).
RN   [120]
RP   VARIANT PLASENCIA ARG-126.
RX   PubMed=15921163; DOI=10.1081/HEM-58578;
RA   Martin G., Villegas A., Gonzalez F.A., Ropero P., Hojas R., Polo M.,
RA   Mateo M., Salvador M., Benavente C.;
RT   "A novel mutation of the alpha2-globin causing alpha(+)-thalassemia:
RT   Hb Plasencia [alpha125(H8)Leu-->Arg (alpha2).";
RL   Hemoglobin 29:113-117(2005).
CC   -!- FUNCTION: Involved in oxygen transport from the lung to the
CC       various peripheral tissues.
CC   -!- SUBUNIT: Heterotetramer of two alpha chains and two beta chains in
CC       adult hemoglobin A (HbA); two alpha chains and two delta chains in
CC       adult hemoglobin A2 (HbA2); two alpha chains and two epsilon
CC       chains in early embryonic hemoglobin Gower-2; two alpha chains and
CC       two gamma chains in fetal hemoglobin F (HbF).
CC   -!- INTERACTION:
CC       P0DMV9:-; NbExp=3; IntAct=EBI-714680, EBI-11820565;
CC       Q9NZD4:AHSP; NbExp=2; IntAct=EBI-714680, EBI-720250;
CC       Q2TAC2:CCDC57; NbExp=3; IntAct=EBI-714680, EBI-2808286;
CC       P00387:CYB5R3; NbExp=2; IntAct=EBI-714680, EBI-1046040;
CC       P68871:HBB; NbExp=22; IntAct=EBI-714680, EBI-715554;
CC       P02100:HBE1; NbExp=3; IntAct=EBI-714680, EBI-6190240;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-714680, EBI-10171697;
CC       P29474:NOS3; NbExp=2; IntAct=EBI-714680, EBI-1391623;
CC   -!- TISSUE SPECIFICITY: Red blood cells.
CC   -!- PTM: The initiator Met is not cleaved in variant Thionville and is
CC       acetylated.
CC   -!- DISEASE: Heinz body anemias (HEIBAN) [MIM:140700]: Form of non-
CC       spherocytic hemolytic anemia of Dacie type 1. After splenectomy,
CC       which has little benefit, basophilic inclusions called Heinz
CC       bodies are demonstrable in the erythrocytes. Before splenectomy,
CC       diffuse or punctate basophilia may be evident. Most of these cases
CC       are probably instances of hemoglobinopathy. The hemoglobin
CC       demonstrates heat lability. Heinz bodies are observed also with
CC       the Ivemark syndrome (asplenia with cardiovascular anomalies) and
CC       with glutathione peroxidase deficiency.
CC       {ECO:0000269|PubMed:2833478}. Note=The disease may be caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Alpha-thalassemia (A-THAL) [MIM:604131]: A form of
CC       thalassemia. Thalassemias are common monogenic diseases occurring
CC       mostly in Mediterranean and Southeast Asian populations. The
CC       hallmark of alpha-thalassemia is an imbalance in globin-chain
CC       production in the adult HbA molecule. The level of alpha chain
CC       production can range from none to very nearly normal levels.
CC       Deletion of both copies of each of the two alpha-globin genes
CC       causes alpha(0)-thalassemia, also known as homozygous alpha
CC       thalassemia. Due to the complete absence of alpha chains, the
CC       predominant fetal hemoglobin is a tetramer of gamma-chains (Bart
CC       hemoglobin) that has essentially no oxygen carrying capacity. This
CC       causes oxygen starvation in the fetal tissues leading to prenatal
CC       lethality or early neonatal death. The loss of two alpha genes
CC       results in mild alpha-thalassemia, also known as heterozygous
CC       alpha-thalassemia. Affected individuals have small red cells and a
CC       mild anemia (microcytosis). If three of the four alpha-globin
CC       genes are functional, individuals are completely asymptomatic.
CC       Some rare forms of alpha-thalassemia are due to point mutations
CC       (non-deletional alpha-thalassemia). Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Alpha(0)-thalassemia is associated with non-immune
CC       hydrops fetalis, a generalized edema of the fetus with fluid
CC       accumulation in the body cavities due to non-immune causes. Non-
CC       immune hydrops fetalis is not a diagnosis in itself but a symptom,
CC       a feature of many genetic disorders, and the end-stage of a wide
CC       variety of disorders.
CC   -!- DISEASE: Hemoglobin H disease (HBH) [MIM:613978]: A form of alpha-
CC       thalassemia due to the loss of three alpha genes. This results in
CC       high levels of a tetramer of four beta chains (hemoglobin H),
CC       causing a severe and life-threatening anemia. Untreated, most
CC       patients die in childhood or early adolescence.
CC       {ECO:0000269|PubMed:10569720}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Gives blood its red color.
CC   -!- SIMILARITY: Belongs to the globin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00238}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD97112.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=HbVar; Note=Human hemoglobin variants and
CC       thalassemias;
CC       URL="http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=directlink&gene=HBA1";
CC   -!- WEB RESOURCE: Name=HbVar; Note=Human hemoglobin variants and
CC       thalassemias;
CC       URL="http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=directlink&gene=HBA2";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HBA1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hemoglobin entry;
CC       URL="https://en.wikipedia.org/wiki/Hemoglobin";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Journey into a tiny
CC       world - Issue 84 of July 2007;
CC       URL="https://web.expasy.org/spotlight/back_issues/084/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J00153; AAB59407.1; -; Genomic_DNA.
DR   EMBL; J00153; AAB59408.1; -; Genomic_DNA.
DR   EMBL; V00491; CAA23750.1; -; Genomic_DNA.
DR   EMBL; V00493; CAA23752.1; -; mRNA.
DR   EMBL; V00488; CAA23748.1; -; Genomic_DNA.
DR   EMBL; V00516; CAA23774.1; -; Genomic_DNA.
DR   EMBL; AF230076; AAF72612.1; -; Genomic_DNA.
DR   EMBL; AF525460; AAM83102.1; -; Genomic_DNA.
DR   EMBL; DQ431198; ABD95910.1; -; Genomic_DNA.
DR   EMBL; DQ431198; ABD95911.1; -; Genomic_DNA.
DR   EMBL; AF097635; AAC72839.1; -; mRNA.
DR   EMBL; AF105974; AAC97373.1; -; mRNA.
DR   EMBL; AF349571; AAK37554.1; -; mRNA.
DR   EMBL; AF536204; AAN04486.1; -; Genomic_DNA.
DR   EMBL; DQ499017; ABF56144.1; -; Genomic_DNA.
DR   EMBL; DQ499018; ABF56145.1; -; Genomic_DNA.
DR   EMBL; AK223392; BAD97112.1; ALT_INIT; mRNA.
DR   EMBL; AE006462; AAK61215.1; -; Genomic_DNA.
DR   EMBL; AE006462; AAK61216.1; -; Genomic_DNA.
DR   EMBL; Z84721; CAB06554.1; -; Genomic_DNA.
DR   EMBL; Z84721; CAB06555.1; -; Genomic_DNA.
DR   EMBL; BC005931; AAH05931.1; -; mRNA.
DR   EMBL; BC008572; AAH08572.1; -; mRNA.
DR   EMBL; BC032122; AAH32122.1; -; mRNA.
DR   EMBL; BC050661; AAH50661.1; -; mRNA.
DR   EMBL; BC101846; AAI01847.1; -; mRNA.
DR   EMBL; BC101848; AAI01849.1; -; mRNA.
DR   CCDS; CCDS10398.1; -.
DR   CCDS; CCDS10399.1; -.
DR   PIR; A90807; HAHU.
DR   PIR; C93303; HACZP.
DR   PIR; I58217; HACZ.
DR   RefSeq; NP_000508.1; NM_000517.4.
DR   RefSeq; NP_000549.1; NM_000558.4.
DR   UniGene; Hs.449630; -.
DR   UniGene; Hs.654744; -.
DR   PDB; 1A00; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1A01; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1A0U; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1A0Z; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1A3N; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1A3O; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1A9W; X-ray; 2.90 A; A/C=2-142.
DR   PDB; 1ABW; X-ray; 2.00 A; A=1-142.
DR   PDB; 1ABY; X-ray; 2.60 A; A=1-142.
DR   PDB; 1AJ9; X-ray; 2.20 A; A=2-142.
DR   PDB; 1B86; X-ray; 2.50 A; A/C=2-142.
DR   PDB; 1BAB; X-ray; 1.50 A; A/C=1-142.
DR   PDB; 1BBB; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1BIJ; X-ray; 2.30 A; A/C=2-142.
DR   PDB; 1BUW; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1BZ0; X-ray; 1.50 A; A/C=2-142.
DR   PDB; 1BZ1; X-ray; 1.59 A; A/C=1-142.
DR   PDB; 1BZZ; X-ray; 1.59 A; A/C=2-142.
DR   PDB; 1C7B; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1C7C; X-ray; 1.80 A; A=2-142.
DR   PDB; 1C7D; X-ray; 1.80 A; A=2-142.
DR   PDB; 1CLS; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1CMY; X-ray; 3.00 A; A/C=2-142.
DR   PDB; 1COH; X-ray; 2.90 A; A/C=2-142.
DR   PDB; 1DKE; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1DXT; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1DXU; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1DXV; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1FDH; X-ray; 2.50 A; A/B=2-142.
DR   PDB; 1FN3; X-ray; 2.48 A; A/C=2-142.
DR   PDB; 1G9V; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 1GBU; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1GBV; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1GLI; X-ray; 2.50 A; A/C=3-142.
DR   PDB; 1GZX; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HAB; X-ray; 2.30 A; A/C=2-142.
DR   PDB; 1HAC; X-ray; 2.60 A; A/C=2-142.
DR   PDB; 1HBA; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HBB; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1HBS; X-ray; 3.00 A; A/C/E/G=2-142.
DR   PDB; 1HCO; X-ray; 2.70 A; A=2-142.
DR   PDB; 1HDB; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1HGA; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HGB; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HGC; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HHO; X-ray; 2.10 A; A=2-142.
DR   PDB; 1IRD; X-ray; 1.25 A; A=2-142.
DR   PDB; 1J3Y; X-ray; 1.55 A; A/C/E/G=2-142.
DR   PDB; 1J3Z; X-ray; 1.60 A; A/C/E/G=2-142.
DR   PDB; 1J40; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 1J41; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 1J7S; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1J7W; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1J7Y; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1JY7; X-ray; 3.20 A; A/C/P/R/U/W=2-142.
DR   PDB; 1K0Y; X-ray; 1.87 A; A/C=2-142.
DR   PDB; 1K1K; X-ray; 2.00 A; A=2-142.
DR   PDB; 1KD2; X-ray; 1.87 A; A/C=2-142.
DR   PDB; 1LFL; X-ray; 2.70 A; A/C/P/R=2-142.
DR   PDB; 1LFQ; X-ray; 2.60 A; A=2-142.
DR   PDB; 1LFT; X-ray; 2.60 A; A=2-142.
DR   PDB; 1LFV; X-ray; 2.80 A; A=2-142.
DR   PDB; 1LFY; X-ray; 3.30 A; A=2-142.
DR   PDB; 1LFZ; X-ray; 3.10 A; A=2-142.
DR   PDB; 1LJW; X-ray; 2.16 A; A=2-142.
DR   PDB; 1M9P; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1MKO; X-ray; 2.18 A; A/C=2-142.
DR   PDB; 1NEJ; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1NIH; X-ray; 2.60 A; A/C=2-142.
DR   PDB; 1NQP; X-ray; 1.73 A; A/C=2-142.
DR   PDB; 1O1I; X-ray; 2.30 A; A=2-142.
DR   PDB; 1O1J; X-ray; 1.90 A; A=2-142.
DR   PDB; 1O1K; X-ray; 2.00 A; A/C=3-142.
DR   PDB; 1O1L; X-ray; 1.80 A; A=2-142.
DR   PDB; 1O1M; X-ray; 1.85 A; A=2-142.
DR   PDB; 1O1N; X-ray; 1.80 A; A=2-142.
DR   PDB; 1O1O; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1O1P; X-ray; 1.80 A; A=2-142.
DR   PDB; 1QI8; X-ray; 1.80 A; A/C=3-142.
DR   PDB; 1QSH; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1QSI; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1QXD; X-ray; 2.25 A; A/C=2-142.
DR   PDB; 1QXE; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 1R1X; X-ray; 2.15 A; A=2-142.
DR   PDB; 1R1Y; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1RPS; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1RQ3; X-ray; 1.91 A; A/C=2-142.
DR   PDB; 1RQ4; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1RQA; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1RVW; X-ray; 2.50 A; A=2-142.
DR   PDB; 1SDK; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1SDL; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1SHR; X-ray; 1.88 A; A/C=2-142.
DR   PDB; 1SI4; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1THB; X-ray; 1.50 A; A/C=2-142.
DR   PDB; 1UIW; X-ray; 1.50 A; A/C/E/G=2-142.
DR   PDB; 1VWT; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1XXT; X-ray; 1.91 A; A/C=2-142.
DR   PDB; 1XY0; X-ray; 1.99 A; A/C=2-142.
DR   PDB; 1XYE; X-ray; 2.13 A; A/C=3-142.
DR   PDB; 1XZ2; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1XZ4; X-ray; 2.00 A; A/C=3-142.
DR   PDB; 1XZ5; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1XZ7; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1XZU; X-ray; 2.16 A; A/C=2-142.
DR   PDB; 1XZV; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1Y01; X-ray; 2.80 A; B=1-142.
DR   PDB; 1Y09; X-ray; 2.25 A; A/C=2-142.
DR   PDB; 1Y0A; X-ray; 2.22 A; A/C=2-140.
DR   PDB; 1Y0C; X-ray; 2.30 A; A/C=2-140.
DR   PDB; 1Y0D; X-ray; 2.10 A; A/C=2-141.
DR   PDB; 1Y0T; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1Y0W; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1Y22; X-ray; 2.16 A; A/C=2-142.
DR   PDB; 1Y2Z; X-ray; 2.07 A; A/C=2-142.
DR   PDB; 1Y31; X-ray; 2.13 A; A/C=2-142.
DR   PDB; 1Y35; X-ray; 2.12 A; A/C=2-142.
DR   PDB; 1Y45; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1Y46; X-ray; 2.22 A; A/C=2-142.
DR   PDB; 1Y4B; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1Y4F; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1Y4G; X-ray; 1.91 A; A/C=2-142.
DR   PDB; 1Y4P; X-ray; 1.98 A; A/C=2-142.
DR   PDB; 1Y4Q; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1Y4R; X-ray; 2.22 A; A/C=2-142.
DR   PDB; 1Y4V; X-ray; 1.84 A; A/C=2-142.
DR   PDB; 1Y5F; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1Y5J; X-ray; 2.03 A; A/C=2-142.
DR   PDB; 1Y5K; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1Y7C; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1Y7D; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1Y7G; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1Y7Z; X-ray; 1.98 A; A/C=2-142.
DR   PDB; 1Y83; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1Y85; X-ray; 2.13 A; A/C=2-142.
DR   PDB; 1Y8W; X-ray; 2.90 A; A/C=2-142.
DR   PDB; 1YDZ; X-ray; 3.30 A; A/C=2-140.
DR   PDB; 1YE0; X-ray; 2.50 A; A/C=2-142.
DR   PDB; 1YE1; X-ray; 4.50 A; A/C=2-142.
DR   PDB; 1YE2; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1YEN; X-ray; 2.80 A; A/C=2-142.
DR   PDB; 1YEO; X-ray; 2.22 A; A/C=2-142.
DR   PDB; 1YEQ; X-ray; 2.75 A; A/C=2-142.
DR   PDB; 1YEU; X-ray; 2.12 A; A/C=2-142.
DR   PDB; 1YEV; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1YFF; X-ray; 2.40 A; A/C/E/G=2-142.
DR   PDB; 1YG5; X-ray; 2.70 A; A/C=2-142.
DR   PDB; 1YGD; X-ray; 2.73 A; A/C=2-142.
DR   PDB; 1YGF; X-ray; 2.70 A; A/C=2-142.
DR   PDB; 1YH9; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1YHE; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1YHR; X-ray; 2.60 A; A/C=2-142.
DR   PDB; 1YIE; X-ray; 2.40 A; A/C=2-142.
DR   PDB; 1YIH; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1YVQ; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1YVT; X-ray; 1.80 A; A=2-142.
DR   PDB; 1YZI; X-ray; 2.07 A; A=2-142.
DR   PDB; 1Z8U; X-ray; 2.40 A; B/D=1-142.
DR   PDB; 2D5Z; X-ray; 1.45 A; A/C=2-142.
DR   PDB; 2D60; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 2DN1; X-ray; 1.25 A; A=2-142.
DR   PDB; 2DN2; X-ray; 1.25 A; A/C=2-142.
DR   PDB; 2DN3; X-ray; 1.25 A; A=2-142.
DR   PDB; 2DXM; Neutron; 2.10 A; A/C=2-142.
DR   PDB; 2H35; NMR; -; A/C=2-142.
DR   PDB; 2HBC; X-ray; 2.10 A; A=2-142.
DR   PDB; 2HBD; X-ray; 2.20 A; A=2-142.
DR   PDB; 2HBE; X-ray; 2.00 A; A=2-142.
DR   PDB; 2HBF; X-ray; 2.20 A; A=2-142.
DR   PDB; 2HBS; X-ray; 2.05 A; A/C/E/G=2-142.
DR   PDB; 2HCO; X-ray; 2.70 A; A=2-142.
DR   PDB; 2HHB; X-ray; 1.74 A; A/C=2-142.
DR   PDB; 2HHD; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 2HHE; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 2M6Z; NMR; -; A/C=2-142.
DR   PDB; 2W6V; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 2W72; X-ray; 1.07 A; A=2-142, C=3-142.
DR   PDB; 2YRS; X-ray; 2.30 A; A/C/I/M=2-142.
DR   PDB; 3B75; X-ray; 2.30 A; A/C/E/G/S=2-142.
DR   PDB; 3D17; X-ray; 2.80 A; A/C=2-142.
DR   PDB; 3D7O; X-ray; 1.80 A; A=2-142.
DR   PDB; 3DUT; X-ray; 1.55 A; A/C=2-142.
DR   PDB; 3HHB; X-ray; 1.74 A; A/C=2-142.
DR   PDB; 3HXN; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 3IA3; X-ray; 3.20 A; B/D=1-142.
DR   PDB; 3IC0; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 3IC2; X-ray; 2.40 A; A/C=2-142.
DR   PDB; 3KMF; Neutron; 2.00 A; A/E=2-142.
DR   PDB; 3NL7; X-ray; 1.80 A; A=2-142.
DR   PDB; 3NMM; X-ray; 1.60 A; A/C=2-142.
DR   PDB; 3ODQ; X-ray; 3.10 A; A/C=2-142.
DR   PDB; 3ONZ; X-ray; 2.09 A; A=2-142.
DR   PDB; 3OO4; X-ray; 1.90 A; A=2-142.
DR   PDB; 3OO5; X-ray; 2.10 A; A=2-142.
DR   PDB; 3OVU; X-ray; 2.83 A; C=2-142.
DR   PDB; 3P5Q; X-ray; 2.00 A; A=2-142.
DR   PDB; 3QJB; X-ray; 1.80 A; A=2-142.
DR   PDB; 3QJC; X-ray; 2.00 A; A=2-142.
DR   PDB; 3QJD; X-ray; 1.56 A; A/C=2-142.
DR   PDB; 3QJE; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 3R5I; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 3S48; X-ray; 3.05 A; C/D=2-142.
DR   PDB; 3S65; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 3S66; X-ray; 1.40 A; A=2-142.
DR   PDB; 3SZK; X-ray; 3.01 A; A/D=2-142.
DR   PDB; 3WCP; X-ray; 1.94 A; A/C=2-142.
DR   PDB; 3WHM; X-ray; 1.85 A; A/E=2-142.
DR   PDB; 4FC3; X-ray; 2.26 A; A=2-142.
DR   PDB; 4HHB; X-ray; 1.74 A; A/C=2-142.
DR   PDB; 4IJ2; X-ray; 4.24 A; A/C=2-142.
DR   PDB; 4L7Y; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 4M4A; X-ray; 2.05 A; A=2-142.
DR   PDB; 4M4B; X-ray; 2.00 A; A=2-142.
DR   PDB; 4MQC; X-ray; 2.20 A; A=2-142.
DR   PDB; 4MQG; X-ray; 1.68 A; A=2-142.
DR   PDB; 4MQH; X-ray; 2.50 A; A=2-140.
DR   PDB; 4MQI; X-ray; 1.92 A; A=2-141.
DR   PDB; 4MQJ; X-ray; 1.80 A; A/C/E/G=2-142.
DR   PDB; 4MQK; X-ray; 2.24 A; A/C/E/G=2-142.
DR   PDB; 4N7N; X-ray; 2.75 A; A/C/E/G/I/K=2-142.
DR   PDB; 4N7O; X-ray; 2.50 A; A/C/E/G/I/K=2-142.
DR   PDB; 4N7P; X-ray; 2.81 A; A/C/E/G/I/K=2-142.
DR   PDB; 4N8T; X-ray; 1.90 A; A=2-142.
DR   PDB; 4NI0; X-ray; 2.15 A; A=2-142.
DR   PDB; 4NI1; X-ray; 1.90 A; A=2-142.
DR   PDB; 4ROL; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 4ROM; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 4WJG; X-ray; 3.10 A; A/F/K/P/U/Z=2-142.
DR   PDB; 4X0L; X-ray; 2.05 A; A=2-142.
DR   PDB; 4XS0; X-ray; 2.55 A; A=2-142.
DR   PDB; 5E29; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 5E6E; X-ray; 1.76 A; A=2-142.
DR   PDB; 5E83; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 5EE4; X-ray; 2.30 A; C/E=2-142.
DR   PDB; 5HU6; X-ray; 2.90 A; A=2-142.
DR   PDB; 5HY8; X-ray; 2.30 A; A/C/E/G/S=2-142.
DR   PDB; 5JDO; X-ray; 3.20 A; C=2-142, E=2-141.
DR   PDB; 5KDQ; X-ray; 2.15 A; A/C=3-142.
DR   PDB; 5KSI; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 5KSJ; X-ray; 2.40 A; A/C=2-142.
DR   PDB; 5NI1; EM; 3.20 A; A/C=2-142.
DR   PDB; 5SW7; X-ray; 1.85 A; A=2-142.
DR   PDB; 5U3I; X-ray; 1.95 A; A/C=2-142.
DR   PDB; 5UCU; X-ray; 1.80 A; A=2-142.
DR   PDB; 5UFJ; X-ray; 2.05 A; A/C=2-142.
DR   PDB; 5URC; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 5VMM; X-ray; 3.60 A; A/C=2-142.
DR   PDB; 5WOG; X-ray; 1.54 A; A/B=3-139.
DR   PDB; 5WOH; X-ray; 1.58 A; A/C=3-139.
DR   PDB; 5X2R; X-ray; 2.70 A; A/C/E/G/I/K=2-142.
DR   PDB; 5X2S; X-ray; 2.39 A; A/C/E/G/I/K=2-142.
DR   PDB; 5X2T; X-ray; 2.64 A; A/C/E/G/I/K=2-142.
DR   PDB; 5X2U; X-ray; 2.53 A; A/C/E/G/I/K=2-142.
DR   PDB; 6BB5; X-ray; 2.28 A; A=3-141.
DR   PDB; 6BWP; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 6BWU; X-ray; 2.00 A; A=2-142.
DR   PDB; 6HBW; X-ray; 2.00 A; A/C=2-142.
DR   PDBsum; 1A00; -.
DR   PDBsum; 1A01; -.
DR   PDBsum; 1A0U; -.
DR   PDBsum; 1A0Z; -.
DR   PDBsum; 1A3N; -.
DR   PDBsum; 1A3O; -.
DR   PDBsum; 1A9W; -.
DR   PDBsum; 1ABW; -.
DR   PDBsum; 1ABY; -.
DR   PDBsum; 1AJ9; -.
DR   PDBsum; 1B86; -.
DR   PDBsum; 1BAB; -.
DR   PDBsum; 1BBB; -.
DR   PDBsum; 1BIJ; -.
DR   PDBsum; 1BUW; -.
DR   PDBsum; 1BZ0; -.
DR   PDBsum; 1BZ1; -.
DR   PDBsum; 1BZZ; -.
DR   PDBsum; 1C7B; -.
DR   PDBsum; 1C7C; -.
DR   PDBsum; 1C7D; -.
DR   PDBsum; 1CLS; -.
DR   PDBsum; 1CMY; -.
DR   PDBsum; 1COH; -.
DR   PDBsum; 1DKE; -.
DR   PDBsum; 1DXT; -.
DR   PDBsum; 1DXU; -.
DR   PDBsum; 1DXV; -.
DR   PDBsum; 1FDH; -.
DR   PDBsum; 1FN3; -.
DR   PDBsum; 1G9V; -.
DR   PDBsum; 1GBU; -.
DR   PDBsum; 1GBV; -.
DR   PDBsum; 1GLI; -.
DR   PDBsum; 1GZX; -.
DR   PDBsum; 1HAB; -.
DR   PDBsum; 1HAC; -.
DR   PDBsum; 1HBA; -.
DR   PDBsum; 1HBB; -.
DR   PDBsum; 1HBS; -.
DR   PDBsum; 1HCO; -.
DR   PDBsum; 1HDB; -.
DR   PDBsum; 1HGA; -.
DR   PDBsum; 1HGB; -.
DR   PDBsum; 1HGC; -.
DR   PDBsum; 1HHO; -.
DR   PDBsum; 1IRD; -.
DR   PDBsum; 1J3Y; -.
DR   PDBsum; 1J3Z; -.
DR   PDBsum; 1J40; -.
DR   PDBsum; 1J41; -.
DR   PDBsum; 1J7S; -.
DR   PDBsum; 1J7W; -.
DR   PDBsum; 1J7Y; -.
DR   PDBsum; 1JY7; -.
DR   PDBsum; 1K0Y; -.
DR   PDBsum; 1K1K; -.
DR   PDBsum; 1KD2; -.
DR   PDBsum; 1LFL; -.
DR   PDBsum; 1LFQ; -.
DR   PDBsum; 1LFT; -.
DR   PDBsum; 1LFV; -.
DR   PDBsum; 1LFY; -.
DR   PDBsum; 1LFZ; -.
DR   PDBsum; 1LJW; -.
DR   PDBsum; 1M9P; -.
DR   PDBsum; 1MKO; -.
DR   PDBsum; 1NEJ; -.
DR   PDBsum; 1NIH; -.
DR   PDBsum; 1NQP; -.
DR   PDBsum; 1O1I; -.
DR   PDBsum; 1O1J; -.
DR   PDBsum; 1O1K; -.
DR   PDBsum; 1O1L; -.
DR   PDBsum; 1O1M; -.
DR   PDBsum; 1O1N; -.
DR   PDBsum; 1O1O; -.
DR   PDBsum; 1O1P; -.
DR   PDBsum; 1QI8; -.
DR   PDBsum; 1QSH; -.
DR   PDBsum; 1QSI; -.
DR   PDBsum; 1QXD; -.
DR   PDBsum; 1QXE; -.
DR   PDBsum; 1R1X; -.
DR   PDBsum; 1R1Y; -.
DR   PDBsum; 1RPS; -.
DR   PDBsum; 1RQ3; -.
DR   PDBsum; 1RQ4; -.
DR   PDBsum; 1RQA; -.
DR   PDBsum; 1RVW; -.
DR   PDBsum; 1SDK; -.
DR   PDBsum; 1SDL; -.
DR   PDBsum; 1SHR; -.
DR   PDBsum; 1SI4; -.
DR   PDBsum; 1THB; -.
DR   PDBsum; 1UIW; -.
DR   PDBsum; 1VWT; -.
DR   PDBsum; 1XXT; -.
DR   PDBsum; 1XY0; -.
DR   PDBsum; 1XYE; -.
DR   PDBsum; 1XZ2; -.
DR   PDBsum; 1XZ4; -.
DR   PDBsum; 1XZ5; -.
DR   PDBsum; 1XZ7; -.
DR   PDBsum; 1XZU; -.
DR   PDBsum; 1XZV; -.
DR   PDBsum; 1Y01; -.
DR   PDBsum; 1Y09; -.
DR   PDBsum; 1Y0A; -.
DR   PDBsum; 1Y0C; -.
DR   PDBsum; 1Y0D; -.
DR   PDBsum; 1Y0T; -.
DR   PDBsum; 1Y0W; -.
DR   PDBsum; 1Y22; -.
DR   PDBsum; 1Y2Z; -.
DR   PDBsum; 1Y31; -.
DR   PDBsum; 1Y35; -.
DR   PDBsum; 1Y45; -.
DR   PDBsum; 1Y46; -.
DR   PDBsum; 1Y4B; -.
DR   PDBsum; 1Y4F; -.
DR   PDBsum; 1Y4G; -.
DR   PDBsum; 1Y4P; -.
DR   PDBsum; 1Y4Q; -.
DR   PDBsum; 1Y4R; -.
DR   PDBsum; 1Y4V; -.
DR   PDBsum; 1Y5F; -.
DR   PDBsum; 1Y5J; -.
DR   PDBsum; 1Y5K; -.
DR   PDBsum; 1Y7C; -.
DR   PDBsum; 1Y7D; -.
DR   PDBsum; 1Y7G; -.
DR   PDBsum; 1Y7Z; -.
DR   PDBsum; 1Y83; -.
DR   PDBsum; 1Y85; -.
DR   PDBsum; 1Y8W; -.
DR   PDBsum; 1YDZ; -.
DR   PDBsum; 1YE0; -.
DR   PDBsum; 1YE1; -.
DR   PDBsum; 1YE2; -.
DR   PDBsum; 1YEN; -.
DR   PDBsum; 1YEO; -.
DR   PDBsum; 1YEQ; -.
DR   PDBsum; 1YEU; -.
DR   PDBsum; 1YEV; -.
DR   PDBsum; 1YFF; -.
DR   PDBsum; 1YG5; -.
DR   PDBsum; 1YGD; -.
DR   PDBsum; 1YGF; -.
DR   PDBsum; 1YH9; -.
DR   PDBsum; 1YHE; -.
DR   PDBsum; 1YHR; -.
DR   PDBsum; 1YIE; -.
DR   PDBsum; 1YIH; -.
DR   PDBsum; 1YVQ; -.
DR   PDBsum; 1YVT; -.
DR   PDBsum; 1YZI; -.
DR   PDBsum; 1Z8U; -.
DR   PDBsum; 2D5Z; -.
DR   PDBsum; 2D60; -.
DR   PDBsum; 2DN1; -.
DR   PDBsum; 2DN2; -.
DR   PDBsum; 2DN3; -.
DR   PDBsum; 2DXM; -.
DR   PDBsum; 2H35; -.
DR   PDBsum; 2HBC; -.
DR   PDBsum; 2HBD; -.
DR   PDBsum; 2HBE; -.
DR   PDBsum; 2HBF; -.
DR   PDBsum; 2HBS; -.
DR   PDBsum; 2HCO; -.
DR   PDBsum; 2HHB; -.
DR   PDBsum; 2HHD; -.
DR   PDBsum; 2HHE; -.
DR   PDBsum; 2M6Z; -.
DR   PDBsum; 2W6V; -.
DR   PDBsum; 2W72; -.
DR   PDBsum; 2YRS; -.
DR   PDBsum; 3B75; -.
DR   PDBsum; 3D17; -.
DR   PDBsum; 3D7O; -.
DR   PDBsum; 3DUT; -.
DR   PDBsum; 3HHB; -.
DR   PDBsum; 3HXN; -.
DR   PDBsum; 3IA3; -.
DR   PDBsum; 3IC0; -.
DR   PDBsum; 3IC2; -.
DR   PDBsum; 3KMF; -.
DR   PDBsum; 3NL7; -.
DR   PDBsum; 3NMM; -.
DR   PDBsum; 3ODQ; -.
DR   PDBsum; 3ONZ; -.
DR   PDBsum; 3OO4; -.
DR   PDBsum; 3OO5; -.
DR   PDBsum; 3OVU; -.
DR   PDBsum; 3P5Q; -.
DR   PDBsum; 3QJB; -.
DR   PDBsum; 3QJC; -.
DR   PDBsum; 3QJD; -.
DR   PDBsum; 3QJE; -.
DR   PDBsum; 3R5I; -.
DR   PDBsum; 3S48; -.
DR   PDBsum; 3S65; -.
DR   PDBsum; 3S66; -.
DR   PDBsum; 3SZK; -.
DR   PDBsum; 3WCP; -.
DR   PDBsum; 3WHM; -.
DR   PDBsum; 4FC3; -.
DR   PDBsum; 4HHB; -.
DR   PDBsum; 4IJ2; -.
DR   PDBsum; 4L7Y; -.
DR   PDBsum; 4M4A; -.
DR   PDBsum; 4M4B; -.
DR   PDBsum; 4MQC; -.
DR   PDBsum; 4MQG; -.
DR   PDBsum; 4MQH; -.
DR   PDBsum; 4MQI; -.
DR   PDBsum; 4MQJ; -.
DR   PDBsum; 4MQK; -.
DR   PDBsum; 4N7N; -.
DR   PDBsum; 4N7O; -.
DR   PDBsum; 4N7P; -.
DR   PDBsum; 4N8T; -.
DR   PDBsum; 4NI0; -.
DR   PDBsum; 4NI1; -.
DR   PDBsum; 4ROL; -.
DR   PDBsum; 4ROM; -.
DR   PDBsum; 4WJG; -.
DR   PDBsum; 4X0L; -.
DR   PDBsum; 4XS0; -.
DR   PDBsum; 5E29; -.
DR   PDBsum; 5E6E; -.
DR   PDBsum; 5E83; -.
DR   PDBsum; 5EE4; -.
DR   PDBsum; 5HU6; -.
DR   PDBsum; 5HY8; -.
DR   PDBsum; 5JDO; -.
DR   PDBsum; 5KDQ; -.
DR   PDBsum; 5KSI; -.
DR   PDBsum; 5KSJ; -.
DR   PDBsum; 5NI1; -.
DR   PDBsum; 5SW7; -.
DR   PDBsum; 5U3I; -.
DR   PDBsum; 5UCU; -.
DR   PDBsum; 5UFJ; -.
DR   PDBsum; 5URC; -.
DR   PDBsum; 5VMM; -.
DR   PDBsum; 5WOG; -.
DR   PDBsum; 5WOH; -.
DR   PDBsum; 5X2R; -.
DR   PDBsum; 5X2S; -.
DR   PDBsum; 5X2T; -.
DR   PDBsum; 5X2U; -.
DR   PDBsum; 6BB5; -.
DR   PDBsum; 6BWP; -.
DR   PDBsum; 6BWU; -.
DR   PDBsum; 6HBW; -.
DR   ProteinModelPortal; P69905; -.
DR   SMR; P69905; -.
DR   BioGrid; 109289; 25.
DR   BioGrid; 109290; 47.
DR   ComplexPortal; CPX-2158; Hemoglobin HbA complex.
DR   ComplexPortal; CPX-2419; Hemoglobin HbA2 complex.
DR   ComplexPortal; CPX-2927; Hemoglobin E complex.
DR   ComplexPortal; CPX-2932; Hemoglobin HbF Variant 1 complex.
DR   ComplexPortal; CPX-2933; Hemoglobin HbF Variant 2 complex.
DR   DIP; DIP-35199N; -.
DR   IntAct; P69905; 33.
DR   MINT; P69905; -.
DR   STRING; 9606.ENSP00000322421; -.
DR   ChEMBL; CHEMBL2887; -.
DR   DrugBank; DB07427; 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine.
DR   DrugBank; DB07428; 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine.
DR   DrugBank; DB02126; 4-Carboxycinnamic Acid.
DR   DrugBank; DB00893; Iron Dextran.
DR   DrugBank; DB09146; Iron saccharate.
DR   DrugBank; DB00358; Mefloquine.
DR   DrugBank; DB07645; SEBACIC ACID.
DR   TCDB; 1.A.107.1.1; the pore-forming globin (globin) family.
DR   CarbonylDB; P69905; -.
DR   iPTMnet; P69905; -.
DR   PhosphoSitePlus; P69905; -.
DR   BioMuta; HBA1; -.
DR   DMDM; 57013850; -.
DR   DOSAC-COBS-2DPAGE; P69905; -.
DR   REPRODUCTION-2DPAGE; IPI00410714; -.
DR   SWISS-2DPAGE; P69905; -.
DR   UCD-2DPAGE; P69905; -.
DR   EPD; P69905; -.
DR   MaxQB; P69905; -.
DR   PaxDb; P69905; -.
DR   PeptideAtlas; P69905; -.
DR   PRIDE; P69905; -.
DR   ProteomicsDB; 12639; -.
DR   ProteomicsDB; 57547; -.
DR   TopDownProteomics; P69905; -.
DR   DNASU; 3039; -.
DR   Ensembl; ENST00000251595; ENSP00000251595; ENSG00000188536.
DR   Ensembl; ENST00000320868; ENSP00000322421; ENSG00000206172.
DR   GeneID; 3039; -.
DR   GeneID; 3040; -.
DR   KEGG; hsa:3039; -.
DR   KEGG; hsa:3040; -.
DR   UCSC; uc002cfv.4; human.
DR   CTD; 3039; -.
DR   CTD; 3040; -.
DR   DisGeNET; 3039; -.
DR   DisGeNET; 3040; -.
DR   EuPathDB; HostDB:ENSG00000188536.12; -.
DR   EuPathDB; HostDB:ENSG00000206172.8; -.
DR   GeneCards; HBA1; -.
DR   GeneCards; HBA2; -.
DR   GeneReviews; HBA1; -.
DR   GeneReviews; HBA2; -.
DR   HGNC; HGNC:4823; HBA1.
DR   HGNC; HGNC:4824; HBA2.
DR   HPA; CAB032534; -.
DR   HPA; CAB038417; -.
DR   HPA; HPA043780; -.
DR   MalaCards; HBA1; -.
DR   MalaCards; HBA2; -.
DR   MIM; 140700; phenotype.
DR   MIM; 141800; gene+phenotype.
DR   MIM; 141850; gene.
DR   MIM; 141860; gene.
DR   MIM; 604131; phenotype.
DR   MIM; 613978; phenotype.
DR   neXtProt; NX_P69905; -.
DR   OpenTargets; ENSG00000188536; -.
DR   OpenTargets; ENSG00000206172; -.
DR   Orphanet; 98791; Alpha-thalassemia - intellectual disability syndrome linked to chromosome 16.
DR   Orphanet; 330041; Autosomal dominant methemoglobinemia.
DR   Orphanet; 163596; Hb Bart's hydrops fetalis.
DR   Orphanet; 93616; Hemoglobin H disease.
DR   PharmGKB; PA29199; -.
DR   eggNOG; KOG3378; Eukaryota.
DR   eggNOG; COG1018; LUCA.
DR   GeneTree; ENSGT00760000119197; -.
DR   HOVERGEN; HBG009709; -.
DR   InParanoid; P69905; -.
DR   KO; K13822; -.
DR   OMA; DKFLCAV; -.
DR   OrthoDB; EOG091G0S0X; -.
DR   PhylomeDB; P69905; -.
DR   TreeFam; TF332328; -.
DR   Reactome; R-HSA-1237044; Erythrocytes take up carbon dioxide and release oxygen.
DR   Reactome; R-HSA-1247673; Erythrocytes take up oxygen and release carbon dioxide.
DR   Reactome; R-HSA-2168880; Scavenging of heme from plasma.
DR   SIGNOR; P69905; -.
DR   ChiTaRS; HBA1; human.
DR   ChiTaRS; HBA2; human.
DR   EvolutionaryTrace; P69905; -.
DR   GeneWiki; HBA2; -.
DR   GeneWiki; Hemoglobin,_alpha_1; -.
DR   GeneWiki; Hemoglobin,_alpha_2; -.
DR   PMAP-CutDB; P69905; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000188536; -.
DR   CleanEx; HS_HBA1; -.
DR   CleanEx; HS_HBA2; -.
DR   ExpressionAtlas; P69905; baseline and differential.
DR   Genevisible; P69905; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0031838; C:haptoglobin-hemoglobin complex; IDA:BHF-UCL.
DR   GO; GO:0005833; C:hemoglobin complex; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0019825; F:oxygen binding; IEA:InterPro.
DR   GO; GO:0005344; F:oxygen carrier activity; IEA:UniProtKB-KW.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   GO; GO:0098869; P:cellular oxidant detoxification; IEA:GOC.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL.
DR   GO; GO:0015671; P:oxygen transport; TAS:UniProtKB.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:BHF-UCL.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:BHF-UCL.
DR   CDD; cd08927; Hb-alpha_like; 1.
DR   Gene3D; 1.10.490.10; -; 1.
DR   InterPro; IPR000971; Globin.
DR   InterPro; IPR009050; Globin-like_sf.
DR   InterPro; IPR012292; Globin/Proto.
DR   InterPro; IPR002338; Haemoglobin_a-typ.
DR   InterPro; IPR002339; Haemoglobin_pi.
DR   Pfam; PF00042; Globin; 1.
DR   PRINTS; PR00612; ALPHAHAEM.
DR   PRINTS; PR00815; PIHAEM.
DR   SUPFAM; SSF46458; SSF46458; 1.
DR   PROSITE; PS01033; GLOBIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Glycation; Glycoprotein;
KW   Heme; Hereditary hemolytic anemia; Iron; Metal-binding;
KW   Oxygen transport; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:13872627,
FT                                ECO:0000269|PubMed:13954546,
FT                                ECO:0000269|PubMed:14093912}.
FT   CHAIN         2    142       Hemoglobin subunit alpha.
FT                                /FTId=PRO_0000052653.
FT   METAL        59     59       Iron (heme distal ligand).
FT   METAL        88     88       Iron (heme proximal ligand).
FT   SITE         12     12       Not glycated.
FT                                {ECO:0000269|PubMed:7358733}.
FT   SITE         57     57       Not glycated.
FT                                {ECO:0000269|PubMed:7358733}.
FT   SITE         61     61       Not glycated.
FT                                {ECO:0000269|PubMed:7358733}.
FT   SITE         91     91       Not glycated.
FT                                {ECO:0000269|PubMed:7358733}.
FT   SITE        100    100       Not glycated.
FT                                {ECO:0000269|PubMed:7358733}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES       8      8       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES       9      9       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      12     12       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES      17     17       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      17     17       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES      25     25       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      36     36       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      41     41       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     103    103       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES     109    109       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES     132    132       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES     135    135       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES     138    138       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   MOD_RES     139    139       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01942}.
FT   CARBOHYD      8      8       N-linked (Glc) (glycation) lysine;
FT                                alternate.
FT   CARBOHYD     17     17       N-linked (Glc) (glycation) lysine;
FT                                alternate.
FT   CARBOHYD     41     41       N-linked (Glc) (glycation) lysine;
FT                                alternate.
FT   CARBOHYD     62     62       N-linked (Glc) (glycation) lysine.
FT   VARIANT       2      2       V -> E (in Thionville; O(2) affinity
FT                                down; dbSNP:rs33981821).
FT                                {ECO:0000269|PubMed:1618774}.
FT                                /FTId=VAR_002719.
FT   VARIANT       3      3       L -> R (in ChongQing; O(2) affinity up;
FT                                dbSNP:rs36030576).
FT                                {ECO:0000269|PubMed:6526652}.
FT                                /FTId=VAR_002720.
FT   VARIANT       6      6       A -> D (in J-Toronto; dbSNP:rs34090856).
FT                                /FTId=VAR_002721.
FT   VARIANT       6      6       A -> P (in Karachi; dbSNP:rs34751764).
FT                                /FTId=VAR_002722.
FT   VARIANT       7      7       D -> A (in Sawara; O(2) affinity up;
FT                                dbSNP:rs33986902).
FT                                {ECO:0000269|PubMed:20980,
FT                                ECO:0000269|PubMed:4744335}.
FT                                /FTId=VAR_002723.
FT   VARIANT       7      7       D -> G (in Swan River;
FT                                dbSNP:rs281864805).
FT                                {ECO:0000269|PubMed:8745434}.
FT                                /FTId=VAR_002724.
FT   VARIANT       7      7       D -> N (in Dunn; O(2) affinity up;
FT                                dbSNP:rs33961916).
FT                                {ECO:0000269|PubMed:478975,
FT                                ECO:0000269|PubMed:7435503}.
FT                                /FTId=VAR_002725.
FT   VARIANT       7      7       D -> V (in Ferndown; O(2) affinity up;
FT                                dbSNP:rs281864805).
FT                                {ECO:0000269|PubMed:7238857}.
FT                                /FTId=VAR_002726.
FT   VARIANT       7      7       D -> Y (in Woodville; O(2) affinity up;
FT                                dbSNP:rs281864806).
FT                                {ECO:0000269|PubMed:3754246}.
FT                                /FTId=VAR_002727.
FT   VARIANT       8      8       K -> E (in Kurosaki; dbSNP:rs34817956).
FT                                {ECO:0000269|PubMed:7558876}.
FT                                /FTId=VAR_002728.
FT   VARIANT      10     10       N -> T (in Broomfield;
FT                                dbSNP:rs281860608).
FT                                /FTId=VAR_038149.
FT   VARIANT      12     12       K -> E (in Anantharaj; dbSNP:rs33938574).
FT                                /FTId=VAR_002729.
FT   VARIANT      13     13       A -> D (in J-Paris 1/J-Aljezur;
FT                                dbSNP:rs35615982).
FT                                /FTId=VAR_002730.
FT   VARIANT      14     14       A -> P (in Ravenscourt Park; causes
FT                                alpha-thalassemia; dbSNP:rs35331909).
FT                                /FTId=VAR_038150.
FT   VARIANT      15     15       W -> R (in Evanston; O(2) affinity up;
FT                                dbSNP:rs33964317).
FT                                {ECO:0000269|PubMed:6725558,
FT                                ECO:0000269|PubMed:6882779}.
FT                                /FTId=VAR_002731.
FT   VARIANT      16     16       G -> R (in Ottawa/Siam;
FT                                dbSNP:rs35816645).
FT                                /FTId=VAR_002732.
FT   VARIANT      17     17       K -> M (in Harbin; slightly unstable;
FT                                dbSNP:rs35210126).
FT                                {ECO:0000269|PubMed:6526652}.
FT                                /FTId=VAR_002733.
FT   VARIANT      17     17       K -> N (in Beijing; dbSNP:rs281860648 and
FT                                dbSNP:rs281860619).
FT                                /FTId=VAR_002734.
FT   VARIANT      19     19       G -> D (in Al-Ain Abu Dhabi;
FT                                dbSNP:rs35993097).
FT                                {ECO:0000269|PubMed:1428941}.
FT                                /FTId=VAR_002735.
FT   VARIANT      19     19       G -> R (in Handsworth; dbSNP:rs34504387).
FT                                /FTId=VAR_002736.
FT   VARIANT      20     20       A -> D (in J-Kurosh).
FT                                /FTId=VAR_002737.
FT   VARIANT      20     20       A -> E (in J-Tashikuergan;
FT                                dbSNP:rs35628685).
FT                                /FTId=VAR_002738.
FT   VARIANT      21     21       H -> Q (in Le Lamentin;
FT                                dbSNP:rs41525149).
FT                                /FTId=VAR_002739.
FT   VARIANT      21     21       H -> R (in Hobart; dbSNP:rs33943087).
FT                                {ECO:0000269|PubMed:3654264}.
FT                                /FTId=VAR_002740.
FT   VARIANT      22     22       A -> D (in J-Nyanza; dbSNP:rs11548605).
FT                                /FTId=VAR_002741.
FT   VARIANT      22     22       A -> P (in Fontainebleau;
FT                                dbSNP:rs34324664).
FT                                /FTId=VAR_002742.
FT   VARIANT      23     23       G -> D (in J-Medellin; dbSNP:rs34608326).
FT                                /FTId=VAR_002743.
FT   VARIANT      24     24       E -> G (in Reims; slightly unstable;
FT                                dbSNP:rs33939421).
FT                                {ECO:0000269|PubMed:2634669}.
FT                                /FTId=VAR_002744.
FT   VARIANT      24     24       E -> K (in Chad; dbSNP:rs281864819).
FT                                /FTId=VAR_002745.
FT   VARIANT      25     25       Y -> H (in Luxembourg; unstable;
FT                                dbSNP:rs281864821).
FT                                {ECO:0000269|PubMed:2599879}.
FT                                /FTId=VAR_002746.
FT   VARIANT      27     27       A -> E (in Shenyang; unstable;
FT                                dbSNP:rs281864822).
FT                                {ECO:0000269|PubMed:7161109}.
FT                                /FTId=VAR_002747.
FT   VARIANT      27     27       A -> V (in Campinas; dbSNP:rs281864822).
FT                                {ECO:0000269|PubMed:14576901}.
FT                                /FTId=VAR_025387.
FT   VARIANT      28     28       E -> D (in Hekinan; dbSNP:rs281865556).
FT                                /FTId=VAR_002748.
FT   VARIANT      28     28       E -> G (in Fort Worth;
FT                                dbSNP:rs281864823).
FT                                /FTId=VAR_002749.
FT   VARIANT      28     28       E -> V (in Spanish town;
FT                                dbSNP:rs281864823).
FT                                {ECO:0000269|PubMed:2752146}.
FT                                /FTId=VAR_002750.
FT   VARIANT      31     31       E -> K (in O-Padova; dbSNP:rs111033605).
FT                                /FTId=VAR_002751.
FT   VARIANT      32     32       R -> K (causes alpha-thalassemia;
FT                                dbSNP:rs281864543).
FT                                {ECO:0000269|PubMed:11410421}.
FT                                /FTId=VAR_025002.
FT   VARIANT      32     32       R -> S (in Prato; unstable;
FT                                dbSNP:rs111033606).
FT                                {ECO:0000269|PubMed:486536}.
FT                                /FTId=VAR_002752.
FT   VARIANT      35     35       L -> R (in Queens/Ogi;
FT                                dbSNP:rs281864825).
FT                                /FTId=VAR_002753.
FT   VARIANT      38     38       P -> PE (in Catonsville).
FT                                {ECO:0000269|PubMed:8448109}.
FT                                /FTId=VAR_002755.
FT   VARIANT      38     38       P -> R (in Bourmedes; dbSNP:rs281864826).
FT                                /FTId=VAR_002754.
FT   VARIANT      41     41       K -> M (in Kanagawa; O(2) affinity up;
FT                                dbSNP:rs281864828).
FT                                {ECO:0000269|PubMed:1634355}.
FT                                /FTId=VAR_002756.
FT   VARIANT      42     42       T -> S (in Miyano; O(2) affinity up;
FT                                dbSNP:rs281860623).
FT                                {ECO:0000269|PubMed:2634665}.
FT                                /FTId=VAR_002757.
FT   VARIANT      44     44       F -> L (in Hirosaki; unstable;
FT                                dbSNP:rs41491146).
FT                                {ECO:0000269|PubMed:1182166}.
FT                                /FTId=VAR_002758.
FT   VARIANT      45     45       P -> L (in Milledgeville; O(2) affinity
FT                                up; dbSNP:rs41514946).
FT                                {ECO:0000269|PubMed:7213661}.
FT                                /FTId=VAR_002759.
FT   VARIANT      45     45       P -> R (in Kawachi; O(2) affinity up;
FT                                dbSNP:rs281864830).
FT                                {ECO:0000269|PubMed:7068434}.
FT                                /FTId=VAR_002760.
FT   VARIANT      46     46       H -> Q (in Bari; dbSNP:rs281860624).
FT                                /FTId=VAR_002761.
FT   VARIANT      46     46       H -> R (in Fort de France; O(2) affinity
FT                                up; dbSNP:rs281864831).
FT                                {ECO:0000269|PubMed:2752146}.
FT                                /FTId=VAR_002762.
FT   VARIANT      48     48       D -> A (in Cordele; unstable;
FT                                dbSNP:rs281864833).
FT                                {ECO:0000269|PubMed:6547117}.
FT                                /FTId=VAR_002763.
FT   VARIANT      48     48       D -> G (in Kokura; also in Umi/Michigan;
FT                                unstable; dbSNP:rs281864833).
FT                                {ECO:0000269|PubMed:7068437}.
FT                                /FTId=VAR_002764.
FT   VARIANT      48     48       D -> H (in Hasharon/Sinai; unstable;
FT                                dbSNP:rs281864834).
FT                                {ECO:0000269|PubMed:5780195}.
FT                                /FTId=VAR_002765.
FT   VARIANT      48     48       D -> Y (in Kurdistan; dbSNP:rs281864834).
FT                                {ECO:0000269|PubMed:8195005}.
FT                                /FTId=VAR_002766.
FT   VARIANT      49     49       L -> R (in Montgomery; dbSNP:rs41392146).
FT                                {ECO:0000269|PubMed:1115799}.
FT                                /FTId=VAR_002767.
FT   VARIANT      50     50       S -> R (in Savaria; dbSNP:rs41518249).
FT                                /FTId=VAR_002768.
FT   VARIANT      51     51       H -> R (in Aichi; slightly unstable;
FT                                dbSNP:rs281864835).
FT                                {ECO:0000269|PubMed:6714429}.
FT                                /FTId=VAR_002769.
FT   VARIANT      52     52       G -> D (in J-Abidjan; dbSNP:rs281864836).
FT                                /FTId=VAR_002770.
FT   VARIANT      52     52       G -> R (in Russ; dbSNP:rs281864837).
FT                                /FTId=VAR_002771.
FT   VARIANT      54     54       A -> D (in J-Rovigo; unstable;
FT                                dbSNP:rs281864838).
FT                                {ECO:0000269|PubMed:4824923}.
FT                                /FTId=VAR_002772.
FT   VARIANT      55     55       Q -> R (in Hikoshima/Shimonoseki;
FT                                dbSNP:rs281864839).
FT                                /FTId=VAR_002773.
FT   VARIANT      57     57       K -> R (in Port Huron;
FT                                dbSNP:rs281864841).
FT                                {ECO:0000269|PubMed:1802882}.
FT                                /FTId=VAR_002774.
FT   VARIANT      57     57       K -> T (in Thailand; dbSNP:rs281864841).
FT                                /FTId=VAR_002775.
FT   VARIANT      58     58       G -> R (in L-Persian Gulf;
FT                                dbSNP:rs281864843).
FT                                /FTId=VAR_002776.
FT   VARIANT      59     59       H -> Q (in Boghe; dbSNP:rs41378349).
FT                                {ECO:0000269|PubMed:10569723}.
FT                                /FTId=VAR_025388.
FT   VARIANT      59     59       H -> Y (in M-Boston/M-Osaka; O(2)
FT                                affinity down; dbSNP:rs281864845).
FT                                {ECO:0000269|PubMed:4521212}.
FT                                /FTId=VAR_002777.
FT   VARIANT      60     60       G -> D (in Adana; unstable; causes alpha-
FT                                thalassemia; dbSNP:rs28928878).
FT                                {ECO:0000269|PubMed:8237999}.
FT                                /FTId=VAR_002778.
FT   VARIANT      60     60       G -> V (in Tottori; unstable;
FT                                dbSNP:rs281864846).
FT                                {ECO:0000269|PubMed:7275660}.
FT                                /FTId=VAR_002779.
FT   VARIANT      61     61       K -> N (in Zambia; dbSNP:rs281860659 and
FT                                dbSNP:rs111033598).
FT                                /FTId=VAR_002780.
FT   VARIANT      61     61       Missing (in Clinic; unstable; causes
FT                                alpha-thalassemia).
FT                                {ECO:0000269|PubMed:10206681}.
FT                                /FTId=VAR_002781.
FT   VARIANT      62     62       K -> N (in J-Buda; dbSNP:rs33985574).
FT                                {ECO:0000269|Ref.80}.
FT                                /FTId=VAR_002782.
FT   VARIANT      62     62       K -> T (in J-Anatolia;
FT                                dbSNP:rs281865558).
FT                                /FTId=VAR_002783.
FT   VARIANT      63     63       V -> M (in Evans; unstable;
FT                                dbSNP:rs41515649).
FT                                {ECO:0000269|PubMed:2606724,
FT                                ECO:0000269|Ref.11}.
FT                                /FTId=VAR_002784.
FT   VARIANT      63     63       Missing (in HBH; hemoglobin Aghia
FT                                Sophia). {ECO:0000269|PubMed:10569720}.
FT                                /FTId=VAR_066401.
FT   VARIANT      64     64       A -> D (in Pontoise; unstable;
FT                                dbSNP:rs281864848).
FT                                {ECO:0000269|PubMed:849454}.
FT                                /FTId=VAR_002785.
FT   VARIANT      65     65       D -> Y (in Persepolis;
FT                                dbSNP:rs281864849).
FT                                /FTId=VAR_002786.
FT   VARIANT      69     69       N -> K (in G-Philadelphia;
FT                                dbSNP:rs1060339). {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_002787.
FT   VARIANT      72     72       A -> E (in J-Habana; dbSNP:rs281864853).
FT                                /FTId=VAR_002788.
FT   VARIANT      72     72       A -> V (in Ozieri; dbSNP:rs281864853).
FT                                /FTId=VAR_002789.
FT   VARIANT      73     73       H -> R (in Daneskgah-Teheran;
FT                                dbSNP:rs281864854).
FT                                /FTId=VAR_002790.
FT   VARIANT      75     75       D -> A (in Lille; dbSNP:rs281864856).
FT                                /FTId=VAR_002791.
FT   VARIANT      75     75       D -> G (in Chapel Hill;
FT                                dbSNP:rs33921047).
FT                                /FTId=VAR_002792.
FT   VARIANT      75     75       D -> N (in G-Pest; dbSNP:rs281864857).
FT                                {ECO:0000269|Ref.80}.
FT                                /FTId=VAR_002793.
FT   VARIANT      76     76       D -> A (in Duan; dbSNP:rs33991223).
FT                                /FTId=VAR_002794.
FT   VARIANT      76     76       D -> H (in Q-Iran; dbSNP:rs281864858).
FT                                /FTId=VAR_002795.
FT   VARIANT      77     77       M -> K (in Noko; dbSNP:rs281864860).
FT                                /FTId=VAR_002796.
FT   VARIANT      77     77       M -> T (in Aztec; dbSNP:rs281864860).
FT                                /FTId=VAR_002797.
FT   VARIANT      78     78       P -> R (in Guizhou; dbSNP:rs281864861).
FT                                /FTId=VAR_002798.
FT   VARIANT      79     79       N -> H (in Davenport; dbSNP:rs111033602).
FT                                {ECO:0000269|PubMed:2101836}.
FT                                /FTId=VAR_002799.
FT   VARIANT      79     79       N -> K (in Stanleyville-2;
FT                                dbSNP:rs281860607).
FT                                /FTId=VAR_002800.
FT   VARIANT      80     80       A -> G (in Singapore; dbSNP:rs281860603).
FT                                /FTId=VAR_012662.
FT   VARIANT      81     81       L -> R (in Ann Arbor; unstable;
FT                                dbSNP:rs281864863).
FT                                {ECO:0000269|PubMed:5033650}.
FT                                /FTId=VAR_002801.
FT   VARIANT      82     82       S -> C (in Nigeria; dbSNP:rs281864864).
FT                                /FTId=VAR_002802.
FT   VARIANT      83     83       A -> D (in Garden State;
FT                                dbSNP:rs281864865).
FT                                /FTId=VAR_002803.
FT   VARIANT      85     85       S -> R (in Etobicoke; O(2) affinity up;
FT                                dbSNP:rs281860612).
FT                                {ECO:0000269|PubMed:6874377}.
FT                                /FTId=VAR_002804.
FT   VARIANT      86     86       D -> V (in Inkster; O(2) affinity up;
FT                                dbSNP:rs41331747).
FT                                {ECO:0000269|PubMed:4212045}.
FT                                /FTId=VAR_002805.
FT   VARIANT      86     86       D -> Y (in Atago; O(2) affinity up;
FT                                dbSNP:rs281864777).
FT                                {ECO:0000269|PubMed:5115619}.
FT                                /FTId=VAR_002806.
FT   VARIANT      87     87       L -> R (in Moabit; unstable;
FT                                dbSNP:rs281864866).
FT                                {ECO:0000269|PubMed:108887}.
FT                                /FTId=VAR_002807.
FT   VARIANT      88     88       H -> N (in Auckland; unstable;
FT                                dbSNP:rs281864868).
FT                                {ECO:0000269|PubMed:9322075}.
FT                                /FTId=VAR_002808.
FT   VARIANT      88     88       H -> R (in Iwata; unstable;
FT                                dbSNP:rs281864867).
FT                                /FTId=VAR_002809.
FT   VARIANT      89     89       A -> S (in Loire; O(2) affinity up;
FT                                dbSNP:rs281864869).
FT                                {ECO:0000269|PubMed:3142772}.
FT                                /FTId=VAR_002810.
FT   VARIANT      91     91       K -> M (in Handa; O(2) affinity up;
FT                                dbSNP:rs281864873).
FT                                {ECO:0000269|PubMed:6815131}.
FT                                /FTId=VAR_002811.
FT   VARIANT      92     92       L -> F (in dbSNP:rs17407508).
FT                                /FTId=VAR_049272.
FT   VARIANT      92     92       L -> P (in Port Phillip; unstable;
FT                                dbSNP:rs17407508).
FT                                {ECO:0000269|PubMed:902765}.
FT                                /FTId=VAR_002812.
FT   VARIANT      93     93       R -> Q (in J-Cape Town; O(2) affinity up;
FT                                dbSNP:rs281864875).
FT                                {ECO:0000269|PubMed:5091982,
FT                                ECO:0000269|PubMed:5988206}.
FT                                /FTId=VAR_002813.
FT   VARIANT      93     93       R -> W (in Cemenelum; O(2) affinity up;
FT                                dbSNP:rs281864876).
FT                                {ECO:0000269|PubMed:8148419}.
FT                                /FTId=VAR_020775.
FT   VARIANT      95     95       D -> A (in Bassett; markedly reduced
FT                                oxygen affinity; dbSNP:rs281864879).
FT                                {ECO:0000269|PubMed:15495251}.
FT                                /FTId=VAR_025389.
FT   VARIANT      95     95       D -> Y (in Setif; unstable;
FT                                dbSNP:rs281864878).
FT                                {ECO:0000269|PubMed:4667378}.
FT                                /FTId=VAR_002814.
FT   VARIANT      96     96       P -> A (in Denmark Hill; O(2) affinity
FT                                up; dbSNP:rs281864881).
FT                                {ECO:0000269|PubMed:5085669}.
FT                                /FTId=VAR_002815.
FT   VARIANT      96     96       P -> T (in Godavari; O(2) affinity up;
FT                                dbSNP:rs281864881).
FT                                {ECO:0000269|PubMed:9494044}.
FT                                /FTId=VAR_002816.
FT   VARIANT      98     98       N -> K (in Dallas; O(2) affinity up;
FT                                dbSNP:rs41338947).
FT                                {ECO:0000269|PubMed:1390940}.
FT                                /FTId=VAR_002817.
FT   VARIANT     100    100       K -> E (in Turriff; dbSNP:rs281864882).
FT                                {ECO:0000269|PubMed:1634357}.
FT                                /FTId=VAR_002818.
FT   VARIANT     103    103       S -> R (in Manitoba; slightly unstable;
FT                                dbSNP:rs41344646).
FT                                {ECO:0000269|PubMed:6547932}.
FT                                /FTId=VAR_002819.
FT   VARIANT     104    104       H -> R (in Contaldo; unstable;
FT                                dbSNP:rs63750752).
FT                                {ECO:0000269|PubMed:6547932}.
FT                                /FTId=VAR_002820.
FT   VARIANT     104    104       H -> Y (in Charolles; dbSNP:rs63750073).
FT                                {ECO:0000269|PubMed:10569723}.
FT                                /FTId=VAR_025390.
FT   VARIANT     110    110       L -> R (in Suan-Dok; unstable; causes
FT                                alpha-thalassemia; dbSNP:rs41479844).
FT                                {ECO:0000269|PubMed:478977}.
FT                                /FTId=VAR_002821.
FT   VARIANT     111    111       A -> D (in Petah Tikva; unstable; causes
FT                                alpha-thalassemia; dbSNP:rs28928889).
FT                                {ECO:0000269|PubMed:7470621}.
FT                                /FTId=VAR_002822.
FT   VARIANT     113    113       H -> D (in Hopkins-II; unstable;
FT                                dbSNP:rs281864885).
FT                                {ECO:0000269|PubMed:5288820}.
FT                                /FTId=VAR_002823.
FT   VARIANT     114    114       L -> H (in Twin Peaks;
FT                                dbSNP:rs281860618).
FT                                /FTId=VAR_002824.
FT   VARIANT     115    115       P -> L (in Nouakchott;
FT                                dbSNP:rs267607269).
FT                                /FTId=VAR_002825.
FT   VARIANT     115    115       P -> R (in Chiapas; dbSNP:rs267607269).
FT                                /FTId=VAR_002826.
FT   VARIANT     115    115       P -> S (in Melusine; dbSNP:rs281864887).
FT                                {ECO:0000269|PubMed:8294199}.
FT                                /FTId=VAR_002827.
FT   VARIANT     116    116       A -> D (in J-Tongariki;
FT                                dbSNP:rs281864888).
FT                                /FTId=VAR_002828.
FT   VARIANT     117    117       E -> A (in Ube-4; dbSNP:rs281864946).
FT                                /FTId=VAR_002829.
FT   VARIANT     117    117       E -> EHLPAE (in Zaire).
FT                                {ECO:0000269|PubMed:1511986}.
FT                                /FTId=VAR_002830.
FT   VARIANT     118    118       F -> FI (in Phnom Penh).
FT                                {ECO:0000269|PubMed:9452028}.
FT                                /FTId=VAR_002831.
FT   VARIANT     119    119       T -> TEFT (in Grady).
FT                                {ECO:0000269|PubMed:4528583}.
FT                                /FTId=VAR_002832.
FT   VARIANT     121    121       A -> E (in J-Meerut/J-Birmingham;
FT                                dbSNP:rs36075744).
FT                                {ECO:0000269|PubMed:7713747}.
FT                                /FTId=VAR_002833.
FT   VARIANT     122    122       V -> M (in Owari; dbSNP:rs35187567).
FT                                /FTId=VAR_002834.
FT   VARIANT     123    123       H -> Q (in Westmead; dbSNP:rs41479347).
FT                                {ECO:0000269|PubMed:1686260}.
FT                                /FTId=VAR_002835.
FT   VARIANT     126    126       L -> P (in Quong Sze; causes alpha-
FT                                thalassemia; dbSNP:rs41397847).
FT                                /FTId=VAR_002836.
FT   VARIANT     126    126       L -> R (in Plasencia; family with
FT                                moderate microcytosis and hypochromia;
FT                                dbSNP:rs41397847).
FT                                {ECO:0000269|PubMed:15921163}.
FT                                /FTId=VAR_025391.
FT   VARIANT     127    127       D -> G (in West One; dbSNP:rs33957766).
FT                                {ECO:0000269|PubMed:14576901}.
FT                                /FTId=VAR_025392.
FT   VARIANT     127    127       D -> V (in Fukutomi; O(2) affinity up;
FT                                dbSNP:rs33957766).
FT                                {ECO:0000269|PubMed:2079432}.
FT                                /FTId=VAR_002837.
FT   VARIANT     127    127       D -> Y (in Montefiore; O(2) affinity up;
FT                                dbSNP:rs33933481).
FT                                {ECO:0000269|PubMed:8798486}.
FT                                /FTId=VAR_002838.
FT   VARIANT     128    128       K -> N (in Jackson; dbSNP:rs33972894).
FT                                /FTId=VAR_002839.
FT   VARIANT     130    130       L -> P (in Tunis-Bizerte; unstable;
FT                                causes alpha-thalassemia;
FT                                dbSNP:rs281864889).
FT                                {ECO:0000269|PubMed:7786798}.
FT                                /FTId=VAR_002840.
FT   VARIANT     131    131       A -> D (in Yuda; O(2) affinity down;
FT                                dbSNP:rs41528545).
FT                                {ECO:0000269|PubMed:1428950}.
FT                                /FTId=VAR_002842.
FT   VARIANT     131    131       A -> P (in Sun Prairie; unstable;
FT                                dbSNP:rs41529844).
FT                                {ECO:0000269|PubMed:2079430}.
FT                                /FTId=VAR_002841.
FT   VARIANT     132    132       S -> P (in Questembert; highly unstable;
FT                                causes alpha-thalassemia;
FT                                dbSNP:rs63751417).
FT                                {ECO:0000269|PubMed:8493987}.
FT                                /FTId=VAR_002843.
FT   VARIANT     134    134       S -> R (in Val de Marne; O(2) affinity
FT                                up; dbSNP:rs41514946).
FT                                {ECO:0000269|PubMed:8294200}.
FT                                /FTId=VAR_002844.
FT   VARIANT     136    136       V -> E (in Pavie; dbSNP:rs63749809).
FT                                /FTId=VAR_002845.
FT   VARIANT     137    137       L -> M (in Chicago; dbSNP:rs41364652).
FT                                /FTId=VAR_002846.
FT   VARIANT     137    137       L -> P (in Bibba; unstable; causes alpha-
FT                                thalassemia; dbSNP:rs41469945).
FT                                {ECO:0000269|PubMed:5440849}.
FT                                /FTId=VAR_002847.
FT   VARIANT     137    137       L -> R (in Toyama; dbSNP:rs41469945).
FT                                {ECO:0000269|PubMed:2833478}.
FT                                /FTId=VAR_035242.
FT   VARIANT     139    139       S -> P (in Attleboro; O(2) affinity up;
FT                                dbSNP:rs63750801).
FT                                {ECO:0000269|PubMed:2108715}.
FT                                /FTId=VAR_002848.
FT   VARIANT     140    140       K -> E (in Hanamaki; O(2) affinity up;
FT                                dbSNP:rs41361546).
FT                                {ECO:0000269|PubMed:1634363}.
FT                                /FTId=VAR_002849.
FT   VARIANT     140    140       K -> T (in Tokoname; O(2) affinity up;
FT                                dbSNP:rs56348461).
FT                                {ECO:0000269|PubMed:6188720}.
FT                                /FTId=VAR_002850.
FT   VARIANT     141    141       Y -> H (in Rouen/Ethiopia; O(2) affinity
FT                                up; dbSNP:rs55870409).
FT                                {ECO:0000269|PubMed:1390944,
FT                                ECO:0000269|PubMed:1428951}.
FT                                /FTId=VAR_002851.
FT   VARIANT     142    142       R -> C (in Nunobiki; O(2) affinity up;
FT                                dbSNP:rs63750134).
FT                                {ECO:0000269|PubMed:3973024}.
FT                                /FTId=VAR_002852.
FT   VARIANT     142    142       R -> H (in Suresnes; O(2) affinity up;
FT                                dbSNP:rs63751282).
FT                                {ECO:0000269|PubMed:7410435}.
FT                                /FTId=VAR_002854.
FT   VARIANT     142    142       R -> L (in Legnano; O(2) affinity up;
FT                                dbSNP:rs63751282).
FT                                {ECO:0000269|PubMed:7462179}.
FT                                /FTId=VAR_002853.
FT   VARIANT     142    142       R -> P (in Singapore; dbSNP:rs63751282).
FT                                /FTId=VAR_002855.
FT   CONFLICT     10     10       N -> H (in Ref. 13; BAD97112).
FT                                {ECO:0000305}.
FT   HELIX         5     18       {ECO:0000244|PDB:2W72}.
FT   HELIX        19     21       {ECO:0000244|PDB:2W72}.
FT   HELIX        22     36       {ECO:0000244|PDB:2W72}.
FT   HELIX        38     43       {ECO:0000244|PDB:2W72}.
FT   STRAND       45     47       {ECO:0000244|PDB:1M9P}.
FT   STRAND       50     52       {ECO:0000244|PDB:1NEJ}.
FT   HELIX        54     72       {ECO:0000244|PDB:2W72}.
FT   TURN         73     75       {ECO:0000244|PDB:2W72}.
FT   HELIX        77     80       {ECO:0000244|PDB:2W72}.
FT   HELIX        82     90       {ECO:0000244|PDB:2W72}.
FT   TURN         91     93       {ECO:0000244|PDB:2M6Z}.
FT   HELIX        97    113       {ECO:0000244|PDB:2W72}.
FT   TURN        115    117       {ECO:0000244|PDB:2W72}.
FT   HELIX       120    138       {ECO:0000244|PDB:2W72}.
FT   HELIX       139    141       {ECO:0000244|PDB:1SDL}.
SQ   SEQUENCE   142 AA;  15258 MW;  15E13666573BBBAE CRC64;
     MVLSPADKTN VKAAWGKVGA HAGEYGAEAL ERMFLSFPTT KTYFPHFDLS HGSAQVKGHG
     KKVADALTNA VAHVDDMPNA LSALSDLHAH KLRVDPVNFK LLSHCLLVTL AAHLPAEFTP
     AVHASLDKFL ASVSTVLTSK YR
//
